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SUMMARY 
Aortic valve (AV) is a dynamic structure that experiences different types of cyclic 
mechanical forces, such as stretch, shear, etc. These mechanical stimuli regulate the 
cellular phenotypes of the valve. Adverse alteration in any of these mechanical stimuli can 
initiate a cascade of pathological events, ultimately leading to AV disease. Since the 
discovery of microRNAs and their regulatory function in modulating gene expression, 
numerous studies have identified several microRNAs with therapeutic potential to treat 
different diseases. Similar studies have also identified many microRNAs related to 
cardiovascular diseases. Among those, miR-214 is a major microRNA that has been found 
to be significantly associated with AV calcification, as well as other cardiovascular 
diseases. 
The objective of the current thesis work was to investigate the functional relation 
between cyclic stretch and miR-214 in promoting AV disease. Elevated cyclic stretch has 
been shown to induce adverse extracellular matrix remodeling and higher calcification in 
AV. An ex vivo stretch bioreactor was used to apply uniaxial cyclic stretch on freshly 
collected porcine AV tissues. The first specific aim sought to understand the effect of 
physiological and pathological levels of cyclic stretch on miR-214 expression in AV. It 
was found that pathological cyclic stretch downregulates miR-214 expression during 
stretch-induced AV calcification. This, in turn, indicates a potentially protective role of 
miR-214 in stretch-induced AV disease. The second specific aim investigated the effect of 
cyclic stretch on the expression of miR-214’s target gene, ATF4 and two other downstream 
genes (CHOP and BCL2L1). It was found that pathological cyclic stretch upregulates 
 xiv 
ATF4 and downregulated pro-survival BCL2L1 expression, which is in line with the high 
ATF4 expression and increased cell apoptosis in calcified human AVs. Pathological cyclic 
stretch didn’t change the expression of CHOP in AV. Since the results of first specific aim 
pointed toward a protective role of miR-214, the effect of miR-214 mimic on ATF4, 
CHOP, BCL2L1 and osteocalcin (calcification related gene) expression was studied in the 
third specific aim. It was found that miR-214 overexpression considerably suppressed the 
expression of ATF4 gene, with lesser effects on the other genes. Together, these results 
may have identified a protective role of miR-214 in stretch-induced AV disease via its 






CHAPTER 1. INTRODUCTION 
1.1 The Heart and The Cardiac Cycle 
The heart is a major organ of the human body. It pumps oxygenated blood returning 
from the lungs to the rest of the body and deoxygenated blood from the right side of the 
heart to the lungs. A normal heart has four chambers – the left and right atria, and the left 
and right ventricles (Figure 1.1a). 
The right (deoxygenated) and left (oxygenated) sides of the heart are separated by a 
muscular wall called the septum. The right atrium collects deoxygenated blood from the 
vena cavae and pumps it via the right ventricle and the pulmonary arteries to the lungs, 
where the blood is oxygenated. The oxygenated blood returns to the left atrium via the 
pulmonary veins and is pumped to the systemic circulation when the left ventricle contracts 
during systole.  
(a) Four chambers (b) Heart valves 
Figure 1.1 – Anatomy of the heart. 
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The heart has four valves (Figure 1.1b): two on each side to maintain unidirectional flow 
of blood through the heart. These valves can be classified into two types based on their 
anatomical location: atrioventricular valves (mitral and tricuspid valve) and semilunar or 
outflow tract valves (aortic and pulmonary valve). The atrioventricular valves have chordae 
tendinae that attach to papillary muscles on the ventricular walls. This structural feature is 
absent in the outflow tract valves. 
A normal cardiac cycle can be divided into several distinct phases. During atrial 
contraction, blood is ejected from the atria into the ventricles resulting in a rise in 
ventricular pressure. A fourth heart sound may be heard at this juncture. At the onset of 
systole, ventricular isovolumic contraction occurs with the closing of the atrioventricular 
Figure 1.2 – Cardiac cycle. 
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valves first followed by all the valves. During this stage, the ventricular volume remains 
constant. In the rapid ejection phase, as soon as the pressure in the left ventricle exceeded 
the pressure in the aorta, the aortic valve opens and blood flows rapidly from the ventricle 
into the aorta. Following rapid ejection, the rate of outflow from the ventricle decreases, 
and the ventricular and aortic pressures start to decrease in the reduced ejection phase.  
At the end of systole, during the isovolumic relaxation phase, the ventricular ejection 
decreases to zero. The left ventricle pressure falls below the pressures in the aorta and 
pulmonary artery, which causes the aortic and pulmonary valves to close (beginning of 
diastolic phase). Once the ventricular pressure falls below the atrial pressure the 
atrioventricular valves open and rapid ventricular filling begins. During this period, the 
flow of blood from the aorta to the peripheral arteries continues, and the aortic pressure 
slowly decreases. This rapid ventricular filling phase is followed by the reduced ventricular 









1.2 The Aortic Valve (AV) 
The aortic valve (AV) is situated at the aortic root and regulates blood flow from the 
left ventricle into the aorta. As shown in Figure 1.3, it consists of three semilunar cusps or 
leaflets, which are attached to a fibrous annulus embedded within the left ventricle and the 
septum. Two adjacent leaflets are attached at the commissures and there is an elliptical 
depression behind each leaflet called the sinus of Valsalva. The left and right sinuses 
contain ostia that lead into the left and right main coronary arteries. The third sinus does 
not feed a coronary artery and is called a non-coronary sinus. Based on their respective 
anatomical positions, the three AV leaflets are thereby named the left coronary cusp (LCC), 
the right coronary cusp (RCC) and the non-coronary cusp (NCC). The basal regions of the 
leaflets are attached to the sinuses of Valsalva, whereas the sinotubular junction (STJ) 
Figure 1.3 – Excised porcine AV (Balachandran, 2010). 
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connects the sinuses to the aorta (Figure 1.4). Hence, the three leaflets, in combination with 
the sinuses of Valsalva, form the functional unit of the aortic valve.  
1.3 Structure of the AV Leaflet 
The AV leaflets are lined with one layer of endothelial cells (ECs) on both the aortic 
(leaflet surface facing the aorta) and ventricular (leaflet surface facing the left ventricle) 
sides. In the interior region, the leaflets are populated with interstitial cells (ICs), which 
represent the most abundant cell type in AV. Each leaflet consists of three distinct layers, 
namely, the fibrosa, the spongiosa and the ventricularis. The fibrosa and the ventricularis 
are located immediately below the endothelial layer on the aortic and ventricular surfaces 
Figure 1.4 – Aortic root anatomy (Charitos et al., 2013). 
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of the leaflet, respectively. The spongiosa lies between the fibrosa and the ventricularis 
(Figure 1.5).  
The fibrosa provides the major load-bearing capacity of the valve leaflet (Wiltz et 
al., 2013). It is mainly composed of circumferentially oriented collagen fibers, which are 
interconnected with radially aligned elastin fibers. The ventricularis, on the other hand, 
primarily consists of elastin fibers. Elastin helps with restoring the crimped state of 
collagen fibers via its recoil action. The spongiosa is mainly composed of 
glycosaminoglycans and proteoglycans. It works as a lubricating layer between the fibrosa 
and the ventricularis to promote flexibility. It also dampens the vibrations arising from a 
closing valve and prevents delamination. 
 
Figure 1.5 – Normal porcine AV leaflet stained with Movat pentachrome, 
demonstrating the trilaminar structure [F = Fiborsa, S = Spongiosa, and V = 
Ventricularis] (Chen et al., 2011). 
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1.4 AV Cell Biology 
The cells of the aortic valve can be broadly categorized into two classes:  
(i) Endothelial cells (ECs): Cells that line the surface of AV leaflets, and  
(ii) Interstitial cells (ICs): Cells that populate the interior region of AV leaflets. 
Homeostasis of both cell types is required to maintain physiological functioning of 
AV. Pathological alteration in one cell type can induce similar adverse alteration in the 
other cell type, which would eventually lead to AV disease (Figure 1.6).  
 
 
Figure 1.6 – Pathological alteration in either cell type (endothelial or interstitial) 
can lead to AV disease (Miller et al., 2011). 
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1.4.1 Endothelial Cells 
Valvular endothelial cells (VECs) form a monolayer on the aortic and ventricular 
surfaces of the aortic valve. Interestingly, the preferential orientation of these cells is 
perpendicular to the direction of blood flow (Deck et al., 1986), which contrasts with the 
parallel alignment of vascular endothelial cells (Langille et al., 1981). These imply a 
significant difference in the mechanical stresses experienced by the valvular and vascular 
endothelial cells (Butcher et al., 2004), which is further emphasized by their distinct 
transcriptional profiles (Butcher et al., 2006). 
In a co-culture model, VECs have been shown to promote a more quiescent 
phenotype of valvular interstitial cells (VICs) (Butcher et al., 2006). Pathological alteration 
in extracellular matrix (ECM) composition prompts VECs to undergo endothelial-to-
mesenchymal transformation (EndMT) (Dahal et al., 2017), leading to AV disease. 
Additionally, endothelial nitric oxide synthase (eNOS) has been shown to protect against 
aortic valve fibrosis (El Accaoui et al., 2014). 
Oscillatory shear stress, as experienced by VECs on the fibrosa side, causes 
upregulation of EndMT genes (Mahler et al., 2014). While EndMT represents an essential 
process during embryogenesis, it is believed that dysregulated EndMT contributes to the 
initiation and progression of AV disease (Chakraborty et al., 2010). Interestingly, Rathan 
et al. (2011) showed that exposure of fibrosa to low oscillatory shear stress results in much 
higher AV calcification compared to the physiological level. 
VECs have been also found to exhibit side-specificity in gene expression under 
shear stress conditions (Holliday et al., 2011), emphasizing the significantly different shear 
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stress profiles on the fibrosa and ventricularis sides of AV in vivo (Kvitting et al., 2004; 
Markl et al., 2005). These side-specific and shear-dependent transcriptional profiles may 
underlie the observed preferential AV calcification on the fibrosa side (Chen et al., 2011). 
1.4.2 Interstitial Cells 
Valvular interstitial cells (VICs) represent the majority of cell population in aortic 
valve. These cells are heterogeneous in nature, comprising of specific cell phenotypes 
(such as smooth muscle cell, fibroblast and myofibroblast). Interstitial cells (ICs) play a 
crucial role in maintaining the physiological function of aortic valve through the regulation 
of extracellular matrix (ECM) protein synthesis and extracellular matrix remodeling 
(Taylor et al., 2003). However, under pathological conditions (such as hemodynamic 
stress), these cells transform into an abnormally activated state from the regular quiescent 
state and promote the initiation and progression of aortic valve disease (Liu et al., 2007).  
Interestingly, VICs have been shown to suppress endothelial-to-mesenchymal 
transformation (EndoMT) (Shapero et al., 2015) and calcification (Hjortnaes et al., 2015) 
of valvular endothelial cells (VECs). Hence, it is evident that VICs regulate the 
physiological function of VECs via cell-cell interactions. 
VICs exhibit significantly different gene expression profiles under different 
pressure conditions (Warnock et al., 2011), matrix elasticity (Ma et al., 2017), stiffness 
(Mabry et al., 2015), etc., representing varying degree of myofibroblastic activation. 
Therefore, mechanical forces have a predominant role in modulating the phenotypic switch 
of interstitial cells. 
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Several genes have been reported to suppress calcification of VICs, such as IL-37 
(Zeng et al., 2017), Klotho (Li et al., 2017), ATG7 (Deng et al., 2017), etc. On the other 
hand, genes like NTF3 (Yao et al., 2017), DPP4 (Choi et al., 2017), HMGB1 (Shen et al., 
2017), etc. promote VIC calcification. So, these highlight the complex nature of VIC 
function and its pathological activation and progression toward aortic valve calcification. 
1.5 AV Tissue Mechanics and Hemodynamics 
AV tissues exhibit viscoelasticity and highly non-linear stress-strain behavior (Billiar 
et al, 2000; Billiar et al, 2000). The internal configuration of the fiber network in AV 
continuously undergoes strain-induced changes, which involve straightening of highly 
crimped collagen fibers and rotation of these fibers toward the axis of stretch (Sacks et al., 
2007). The AV leaflets experience tensile and bending stresses during the cardiac cycle 
(Figure 1.7). Interestingly, majority of the stresses and strains occur during diastole and 
(a) Peak Systole (b) Peak Diastole 
Figure 1.7 – Mechanical forces experienced by AV (Balachandran et al., 2011). 
 11 
early systole. The total stresses, as a combination of bending and membrane stretching, 
were found to be in the order of 50 kPa during systole and 500 kPa during diastole. These 
result into a 10% leaflet stretching in the circumferential direction from peak systole to 
peak diastole (Thubrikar et al., 1986; Thubrikar et al., 1986; Thubrikar et al., 1979).  
Additionally, the fibrosa and ventricularis sides of AV experience bidirectional 
oscillatory shear stress and unidirectional pulsatile shear stress, respectively (Balachandran 
et al., 2011) (Figure 1.7). The peak value of the unidirectional pulsatile shear stress was 
found to be around 80 dyne/cm2, whereas the one for the bidirectional oscillatory shear 
stress was ± 10 dyne/cm2 (Rathan et al., 2016; Yap et al., 2012; Yap et al., 2012; Rathan 
et al., 2011; Ge et al., 2009; Cao et al., 2016).  
To ensure healthy functioning of AV, it is highly important that all mechanical forces 
lie within respective physiological ranges. Any significant deviation from the physiological 
range may initiate sustained pathological responses at the cellular and tissue levels, 
ultimately leading to AV disease. 
1.6 Effect of Mechanical Stretch on AV 
Elevated cyclic stretch (15%) was found to induce increased extracellular matrix 
(ECM) remodeling in AV by upregulating the expression of Matrix Metalloproteinase 2 
and 9 (MMP-2 and -9), Cathepsin S, Cathepsin K, etc. (Balachandran et al., 2009). In 
addition to that, cellular proliferation and apoptosis in AV was significantly higher under 
15% stretch (Balachandran et al., 2009). Interestingly, higher cyclic stretch (15%) also 
resulted in increased AV calcification compared to the physiological level (10%), including 
upregulation of calcification-related genes, such as Bone Morphogenetic Protein-4 (BMP-
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4), Runt related Transcription Factor 2 (RUNX2), Osteocalcin, etc. (Balachandran et al., 
2010). Hence, pathologically high cyclic stretch (15%) contributes to AV pathogenesis by 
promoting adverse ECM remodeling and calcification, as opposed to the maintenance of 
AV homeostasis by physiological stretch (10%). 
1.7 AV Stenosis and Treatment Options 
Aortic valve (AV) stenosis or aortic stenosis (AS) is characterized by narrowing of 
the valve opening during systole (Figure 1.8, top row), resulting in a larger pressure 
gradient between the left ventricle and the aorta. Under this situation, the left ventricle must 
work harder to overcome the increased afterload caused by the stenotic AV. This is like 
attaching smaller and smaller nozzles to the end of a garden hose. The narrowing from the 
Figure 1.8 – AV stenosis (Mayo Clinic). 
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nozzle slows the forward flow of water and results in progressive pressure buildup within 
the garden hose (Figure 1.8, bottom row).   
The main reason behind the occurrence of AS is thickening and calcification of AV 
leaflets, preferentially on the fibrosa side (Figure 1.9). Normally, the pressure gradient 
across a healthy aortic valve is only a few mm Hg. However, with progressive narrowing 
of AV opening, the pressure gradient increases gradually. A mild stenosis is characterized 
by a pressure gradient of around 20 mm Hg. When the pressure gradient ranges between 
20 and 40 mm Hg, it is indicated as moderate stenosis. A case of severe stenosis happens 
when the pressure gradient is higher than 40 mm Hg (Cleveland Clinic).  
In a recent study, Osnabrugge et al. (2013) found that more than 12% of the elderly 
population (age ≥ 75 years) are diagnosed with AS, with more than 3% representing the 
severe case. In addition to that, severe AS has a worse prognosis than many metastatic 
cancers (New Heart Valve). Hence, this disease poses a significant burden on the elderly 
population. At present, there is no therapeutic drug available to treat AS. The only available 
treatment options are either surgical aortic valve replacement (SAVR) or transcatheter 
aortic valve replacement (TAVR). SAVR is the gold standard for treating severe AS in 
Figure 1.9 – Movat pentachrome stain of a calcified human AV, demonstrating 
maladaptive ECM remodeling and calcification (purple). Scale bar is 1 mm. 
(Chen et al., 2011). 
 14 
operable patients, whereas TAVR offers a minimally invasive, catheter-based treatment 
option for inoperable AS patients (Leon et al., 2016; Kodali et al., 2012; Smith et al., 2011). 
There are two different types of prosthetic heart valves available for SAVR (Figure 1.10): 
(i) mechanical (generally used in younger AS patients) and (ii) bioprosthetic (generally 
used in older AS patients). On the other hand, there are a few FDA-approved transcatheter 
(a) Carpentier-Edwards PERIMOUNT 
Magna Ease Bioprosthetic Aortic Valve 
(b) St. Jude Medical Regent 
Mechanical Heart Valve 
Figure 1.10 – Prosthetic heart valves. 
(a) Edwards SAPIEN 3 (b) Medtronic CoreValve 
Figure 1.11 – Transcatheter heart valves. 
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heart valves used in TAVR, such as the Edwards SAPIEN 3 valve and Medtronic 
CoreValve (Figure 1.11).  
1.8 Endoplasmic Reticulum (ER) Stress 
Endoplasmic reticulum (ER) facilitates proper folding and maturation of proteins 
before these are delivered to other cellular compartments. ER stress occurs when there is 
an accumulation of unfolded proteins in the ER lumen, leading to the activation of unfolded 
protein response (UPR) signaling pathways. In the case of prolonged activity of the UPR 
signaling pathways, mitigation of ER stress becomes impossible and cellular apoptosis 
takes place (Walter et al., 2011; Xu et al., 2005). 
There are three main branches of the UPR signaling pathways (Figure 1.12). These 
are: (i) Activating Transcription Factor 6 (ATF6) mediated pathway, (ii) PRKR-Like 
Endoplasmic Reticulum Kinase (PERK)/Eukaryotic Translation Initiation Factor-2α 
(eIF2α) mediated pathway, and (iii) Inositol-Requiring Enzyme 1 (IRE1) mediated 
pathway.  
Figure 1.12 – ER stress pathways (Wang et al., 2014). 
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Since part of this thesis focuses on the PERK/eIF2α mediated ER stress pathway, the 
following sections present a detailed description of this signaling branch and its 
associations with cardiovascular disease: 
1.8.1 PERK/eIF2α mediated ER Stress Pathway 
PERK is a type I transmembrane protein of ER. Under non-stress conditions, Heat 
Shock Protein 90 (HSP90) and Binding Immunoglobulin Protein (BIP) bind to the 
cytoplasmic and ER luminal domains of PERK, respectively, and prevents its activation. 
However, under ER stress conditions, BIP binds to unfolded and misfolded proteins. This, 
in turn, releases PERK and activates it via homodimerization and autophosphorylation. 
PERK activation is followed by phosphorylation of eIF2α, which results in attenuation of 
translation initiation and shutdown of protein synthesis (Wang et al., 2014; Walter et al., 
2011).  
Paradoxically, PERK-eIF2α activation increases the translation of a select group of 
mRNAs, such as that encoding Activating Transcription Factor 4 (ATF4). ATF4 then 
enters the nucleus and activates the transcription of several ER stress response genes, 
including C/EBP Homologous Protein (CHOP). CHOP expression promotes protein 
synthesis to induce protein misfolding and oxidative stress, eventually leading to cell death. 
It also downregulates the expression of pro-survival genes (such as BCL2L1) (Noh et al., 
2015). However, chronic activation of PERK is required to induce a significant increase in 
the steady state levels of CHOP expression (Wang et al., 2014; Walter et al., 2011). 
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1.8.2 PERK/eIF2α Pathway in Cardiovascular Diseases 
ATF4 and CHOP expression was found to be significantly upregulated in the 
myocardium of heart failure patients (Fu et al., 2010). Similar upregulation was also 
observed in calcified human AV samples compared to healthy control (Wang et al., 2017; 
Cai et al., 2013). In atherosclerosis, ruptured plaques were found to exhibit significantly 
increased CHOP expression (Myoishi et al., 2007). These imply that PERK/eIF2α pathway 
is significantly upregulated in cardiovascular diseases and can be a potential target for 
therapeutic applications (Minamino et al., 2010). 
1.9 miR-214 in Cardiovascular Diseases 
microRNAs are small (~ 22 nucleotides in length) non-coding RNAs that modulate 
gene expression by silencing their targets (Ha et al., 2014). Since discovery of the first 
microRNA (lin-4) in 1993 (Lee et al., 1993), these have been implicated in nearly all 
developmental and pathological processes (Sun et al., 2010). Due to their role in 
modulating gene expression, microRNAs have been widely considered as a potential 
therapeutic option for different diseases, such as cancer (Rupaimoole et al., 2017; Shah et 
al., 2016).  
Many microRNAs have been found to be involved with cardiovascular diseases 
(McManus et al., 2015; Romaine et al., 2013; Quiat et al., 2013). Among these, miR-214 
is of paramount importance due to its regulatory role in physiological and pathological 
processes of the cardiovascular system (Figure 1.13). 
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The expression of miR-214 is upregulated during myocardial infarction (Van Rooij 
et al., 2008) and inhibits left ventricular remodeling by targeting Phosphatase and Tensin 
Homolog (PTEN) (Yang et al., 2016). Upregulated expression of miR-214 plays a 
protective role against ischemic injury by suppressing the expression of Sodium/Calcium 
Exchanger 1 (NCX1) (Aurora et al., 2012). This protective role is associated with its 
inhibitory effect on cardiac fibrosis (Dong et al., 2016). Additionally, circulating miR-214 
expression was found to be correlated with the severity of coronary artery disease (CAD) 
(Jin et al., 2015; Lu et al., 2013).  
miR-214 expression is upregulated during cardiac hypertrophy (Van Rooij et al., 
2006) and overexpression of miR-214 promotes hypertrophy by suppressing Enhancer of 
Zeste Homolog 2 (EZH2) expression (Yang et al., 2014). Similar upregulation of miR-214 
expression is observed in heart failure patients (Duan et al., 2015). On the other hand, the 
expression of miR-214 is downregulated during dilated cardiomyopathy (Baumgarten et 
al., 2013). 
Figure 1.13 – miR-214 in cardiovascular diseases (Zhang et al., 2017). 
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Interestingly, hypoxia induces upregulation of miR-214 expression in a model of 
pulmonary arterial hypertension (PAH) and loss of miR-214 leads to right ventricle 
hypertrophy (RVH) (Stevens et al., 2016). Similar upregulation of left ventricular miR-214 
expression was observed in an Angiotensin II (AngII) infusion model of hypertension 
(McGinnigle et al., 2017). On the contrary, Liu et al. (2016) reported that miR-214 
promotes hypoxia-induced pulmonary hypertension by suppressing the expression of 
Cyclin L2 (CCNL2).  
miR-214 exerts a proliferative effect on vascular smooth muscle by targeting PTEN 
(Zhong et al., 2016), whereas inhibition of miR-214 restores their contractile phenotype by 
upregulating the expression of Myocyte Enhancer Factor 2C (MEF2C) and Leiomodin 
1(LMOD1) (Sahoo et al., 2016).  
In AV disease, the functional role of miR-214 is not clear yet. Song et al. (2017) and 
Wang et al. (2017) reported that calcified human AVs exhibit a decreased expression of 
miR-214 compared to normal control, whereas Li et al. (2016) and Xu et al. (2017) found 
the opposite. In a recent study, Rathan et al. (2016) showed that miR-214 is a side-specific 
microRNA in AV and its expression is upregulated when fibrosa is exposed to low 
oscillatory shear stress. However, this increased expression was found to provide a 
protective effect against AV fibrosis by downregulating the expression of Transforming 
Growth Factor-β1 (TGF-β1).  
Therefore, it is evident that miR-214 has a diversified role in cardiovascular diseases. 
Fundamental understanding of its functional role will be necessary to elucidate the 
underlying mechanisms behind its association with different pathological conditions. 
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1.10 Rationale for Thesis Research 
miR-214 has been shown to be a side-specific and shear-dependent microRNA in 
porcine AVs (Rathan et al., 2016). In addition to that, ATF4 and CHOP (downstream genes 
in the PERK/eIF2α mediated ER stress pathway) expression was found to be upregulated 
during AV calcification (Wang et al., 2017; Cai et al., 2013). Interestingly, ATF4 has been 
reported to be a target of miR-214 (Wang et al., 2013).  
Since stretch is one of the major mechanical forces experienced by AV 
(Balachandran et al., 2011) and elevated stretch induces significantly higher AV 
calcification (Balachandran et al., 2010), it will be interesting to explore the effect of cyclic 
stretch on the expression of miR-214 and its target ER stress response genes (such as 
ATF4). Hence, this dissertation will focus on investigating the role of miR-214 in stretch-
induced AV disease. An ex vivo approach using whole porcine AV tissues was adopted 
since it retains both the cells and the native extracellular matrix. Three specific aims have 
been designed to study the role of miR-214 in stretch-induced AV disease.  
The first specific aim will elucidate the effect of cyclic stretch on miR-214 expression 
in AV. The second specific aim will evaluate the effect of cyclic stretch on ATF4 (miR-
214 target) and its downstream genes, CHOP and BCL2L1. The third specific aim will 
explore the effect of miR-214 mimic on ATF4, CHOP, BCL2L1 and osteocalcin 
(calcification gene) expression in AV. In combination, this information will provide a 
better understanding of the functional role of miR-214 in AV disease. 
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CHAPTER 2. HYPOTHESIS AND SPECIFIC AIMS 
 Cyclic stretch is one of the major mechanical forces as experienced by AV 
(Balachandran et al., 2011). Previously, elevated cyclic stretch (15%) was shown to 
promote adverse extracellular matrix (ECM) remodeling and calcification in AV 
(Balachandran et al., 2009; Balachandran et al., 2010). In a recent study, Rathan et al. 
(2016) reported that increased expression of side-specific and shear-dependent miR-214 
can suppress AV fibrosis by downregulating TGF-β1 expression. In addition to that, miR-
214 expression was found to be downregulated in calcified human AVs compared to 
healthy control (Song et al., 2017; Wang et al., 2017).  
Interestingly, the expression of ATF4 (a target of miR-214) and CHOP 
(transcriptional target of ATF4) are significantly upregulated in calcified human AVs 
compared to normal control (Wang et al., 2017; Cai et al., 2013). CHOP also downregulates 
the expression of pro-survival gene BCL2L1 under apoptotic conditions (Noh et al., 2015). 
It should be noted here that both ATF4 and CHOP are major components of the ER stress 
pathways (Ron et al., 2007). Therefore, it will be interesting to see the effect of cyclic 
stretch on the expression of miR-214 and its target ER stress response genes (such as 
ATF4). 
The hypothesis of this dissertation is that pathological cyclic stretch dysregulates the 
expression of miR-214 as well as those of its target ATF4 and subsequent downstream 
genes, CHOP and BCL2L1 in AV. Additionally, it is hypothesized that miR-214 
overexpression reverses the above-mentioned changes in gene expression and suppresses 
osteocalcin expression in AV.  
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The hypotheses will be tested via three specific aims as follows: 
1) Effect of cyclic stretch on miR-214 expression in AV 
2) Effect of cyclic stretch on ATF4, CHOP and BCL2L1 expression in AV 
3) Effect of miR-214 mimic on ATF4, CHOP, BCL2L1 and osteocalcin expression in 
AV 







Pathological Cyclic Stretch 
miR-214 Expression 
Aim 1 
Pathological Cyclic Stretch 




ATF4, CHOP, Osteocalcin and 
BCL2L1 Expression 
Aim 3 
Figure 2.1 – Overall organization of specific aims. 
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2.1 Effect of Cyclic Stretch on miR-214 Expression in AV 
This specific aim will focus on elucidating the effect of cyclic stretch on miR-214 
expression in AV. miR-214 has been recently identified as one of the side-specific and 
shear-dependent miRNAs in porcine AVs (Rathan et al., 2016), emphasizing its potential 
role in AV pathogenesis. Since stretch is a major mechanical force that is experienced by 
AV during each cardiac cycle, it will be interesting to see its effect on miR-214 expression. 
The hypothesis of this specific aim is that pathological cyclic stretch can dysregulate the 
expression of miR-214 in AV. 
Porcine AV tissues will be cyclically stretched at the physiological (10%) and 
pathological (15%) level for 2 days in regular medium and for 7 days in osteogenic 
medium. Cyclic stretching at 15% for 2 days in regular medium and for 7 days in 
osteogenic medium will represent the stretch-induced early remodeling and late 
calcification stages of AV disease, respectively. For both cases, 10% cyclic stretch will 
serve as the physiological counterpart (2-day 10% stretch in regular medium and 7-day 
10% stretch in osteogenic medium, respectively). Subsequently, the expression of miR-






2.2 Effect of Cyclic Stretch on ATF4, CHOP and BCL2L1 Expression in AV 
This specific aim will focus on elucidating the effect of cyclic stretch on the mRNA 
expression of ATF4, CHOP and BCL2L1 genes in AV. ATF4 and CHOP are major 
components of the ER stress pathways and pro-survival gene BCL2L1 can be 
downregulated by CHOP under apoptotic conditions (Ron et al., 2007; Noh et al., 2015). 
It has been shown that both ATF4 and CHOP are significantly upregulated in calcified 
human AVs compared to healthy control (Cai et al., 2013; Wang et al., 2017). Therefore, 
it will be interesting to see the effect of cyclic stretch on the mRNA expression of ATF4, 
CHOP and BCL2L1 genes in AV. The hypothesis of this specific aim is that pathological 
cyclic stretch can dysregulate the expression of ATF4, CHOP and BCL2L1 genes in AV. 
Porcine AV tissues will be cyclically stretched at the physiological (10%) and 
pathological (15%) level for 2 days in regular medium and for 7 days in osteogenic 
medium. Cyclic stretching at 15% for 2 days in regular medium and for 7 days in 
osteogenic medium will represent the stretch-induced early remodeling and late 
calcification stages of AV disease, respectively. For both cases, 10% cyclic stretch will 
serve as the physiological counterpart (2-day 10% stretch in regular medium and 7-day 
10% stretch in osteogenic medium, respectively). Subsequently, the mRNA expression of 





2.3 Effect of miR-214 Mimic on ATF4, CHOP, BCL2L1 and Osteocalcin 
Expression in AV 
This specific aim will focus on elucidating the effect of miR-214 overexpression on 
the mRNA expression of ATF4, CHOP, BCL2L1 and osteocalcin (BGLAP) genes in AV. 
ATF4 has been reported to be a target of miR-214 (Wang et al., 2013). Interestingly, both 
CHOP and BGLAP are transcriptional targets of ATF4 (Ron et al., 2007; Lian et al., 2009). 
As mentioned previously, increased CHOP expression may downregulate the expression 
of pro-survival gene BCL2L1 under apoptotic conditions (Noh et al., 2015). Therefore, it 
will be interesting to see the effect of miR-214 mimic on the mRNA expression of ATF4, 
CHOP, BCL2L1 and BGLAP genes in AV. The hypothesis of this specific aim is that miR-
214 overexpression can downregulate the expression of ATF4, CHOP and BGLAP genes 
and upregulate the expression of BCL2L1 gene in AV tissues. 
Porcine AV tissues will be statically cultured with either negative control mimic or 
miR-214 mimic for 2 days in osteogenic medium. Use of osteogenic medium will promote 
a calcific environment. Subsequently, miR-214 expression as well as the mRNA expression 
of ATF4, CHOP, BCL2L1 and BGLAP genes will be evaluated in the resulting AV tissue 




CHAPTER 3. METHODS 
3.1 Stretch Bioreactor System 
The stretch bioreactor system used in this dissertation was previously designed and 
validated in the Cardiovascular Fluid Mechanics Laboratory (Balachandran, 2010). The 
following figure indicates the main features of the stretch bioreactor.  
Briefly, the bioreactor has two identical chambers, each containing 8 wells for 
culturing 16 tissues at the same time (one tissue sample per well). Each well can contain 
approximately 5 mL of culture medium. There are two stainless steel posts in each well – 
one stationary and the other mobile. The stationary post is fixed to the bottom surface of 
Figure 3.1 – Stretch bioreactor. 
 27 
each well, whereas the moving post is mounted from an H-shaped arm that is coupled to a 
rigid, stainless steel rod. This stainless-steel rod is further coupled to a cross-arm and a 
linear actuator (ULTRA MOTION part no. D-A.083-HT17-2-2NO-ES-BR/RC4). The 
motion of the linear actuator is controlled by a ST5-Si stepper motor drive (APPLIED 
MOTION), which is connected to a laptop. Appropriate stretch program (10% or 15% 
stretch, Si ProgrammerTM, APPLIED MOTION) is downloaded from the laptop to the 
motor drive to initiate a cyclic stretch experiment. This whole setup is depicted in the 
following diagram: 
Additionally, each chamber of the bioreactor is always covered with a transparent 
lid, while the stainless-steel rods are covered with rubber bellows on the outside of the 
bioreactor. These provide the necessary environmental sealing to ensure sterile operation. 
The stretch bioreactor system is made of polysulfone (most of the parts) and 
polycarbonate (chamber lids) for biocompatibility. Prior to each stretch experiment, the 







Figure 3.2 – Setup of stretch bioreactor system. 
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3.2 Workflow of Ex vivo Stretch Experiment 
The following diagram outlines the workflow for setting up and running an ex vivo 
stretch experiment: 
Each of the above steps is detailed described below: 
3.2.1 Harvesting of Porcine Aortic Valve (AV) Tissue 
Healthy porcine hearts are obtained immediately (within 10 – 15 minutes) after 
slaughter from a local abattoir (HOLIFIELD FARMS, COVINGTON, GA). The three AV 
leaflets from each heart are excised using a surgical scissor and stored in a 50-mL tube 
(VWR catalogue no. 89004-364) containing sterile, DNase/RNase-free ice-cold 
Dulbecco’s Phosphate-Buffered Saline (DPBS; THERMO FISHER SCIENTIFIC 
catalogue no. 21600044) solution on-site. After excising the required number of AV 
leaflets, these are transported back to the laboratory (transportation time does not exceed 1 













Section of AV 
Leaflet 
Sprung Section of 
AV Leaflet 
Set Up and Run 
Stretch 
Experiment 
Figure 3.3 – Workflow for setting up a stretch experiment 
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hour). All tools (metallic tray, forceps, surgical scissors) used in the harvesting process are 
sterile. 
3.2.2 Stretch Experiment Setup 
Upon arriving in the laboratory, excised AV leaflets are transferred to petri dishes 
(VWR catalogue no. 25373-085) containing sterile, DNase/RNase-free ice-cold DPBS 
solution inside a Class II Biological Safety Cabinet. From thereon, all the following steps 
are carried out inside the safety cabinet. A rectangular section of 16 mm (in the 
circumferential direction) by 8 mm (in the radial direction) is cut from the belly region of 
each AV leaflet tissue using a surgical blade (VWR catalogue no. 2976#10) and stored in 
sterile, DNase/RNase-free ice-cold DPBS solution. Next, two stainless steel springs 
(MCMASTER CARR part no. 9663K16) are manually inserted (an optimum of four turns 
or insertions) on either side (circumferential direction) of each tissue section so that the 
tissue section covers at least half the inner diameter of the spring.  
After completion of the springing step, the tissue sections are statically kept in sterile 
regular culture medium. Next, 5 mL of regular or osteogenic culture medium (depending 
on the type of experiment) is added to each well of the stretch bioreactor. Then, each sprung 
tissue section is mounted between the stationary and moving posts of one of the bioreactor 
wells. Once all the sprung tissue sections are mounted inside the wells of the bioreactor, 
the moving post is incrementally moved away from the stationary post to a final position 
where the distance between two posts is 18.7–19 mm (as measured by slide callipers). This 
distance approximately corresponds to an unstretched initial condition for each tissue 
section.  
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After that, the appropriate stretch program is downloaded from the laptop to the 
ST5-Si stepper motor drive that controls the linear actuator of the bioreactor and the 
program is thereby executed to start the cyclic stretch experiment at 60 cycles/minute.  
Next, it is quickly checked (both visually and quantitatively by slide callipers) 
whether all the tissue sections are being cyclically stretched in an appropriate manner. 
Finally, the stretch bioreactor system is carefully transferred from the biological safety 
cabinet to a humid CO2 incubator. Throughout the duration of the stretch experiment, the 
following operating conditions are maintained inside the incubator: 
Table 3.1 – Operating conditions inside the incubator 
Operating Variable Operating Condition 
Chamber Temperature 37°C 
CO2 Concentration 5% 
It is ensured that all tools (tweezers, scalpel handle, surgical blades, springs, allen 
key) and the stretch bioreactor system (including the moving posts and assembly screws) 
are sterilized by ethylene oxide (Anprolene AN74j Sterilizer, ANDERSEN PRODUCTS) 
beforehand. Additionally, aseptic techniques are strictly followed and 70% ethanol (VWR 
catalogue no. 71002-398) and RNase AWAY decontaminant solution (VWR catalogue no. 




3.2.3 Replacing Culture Medium 
Over the course of a stretch experiment, the culture medium is replaced every 48 
hours. It is ensured that the 2 – 200 µL (VWR catalogue no. 47745-170) and 50 – 1000 µL 
(VWR catalogue no. 47745-174) pipet tips are autoclaved beforehand. Additionally, 
aseptic techniques are strictly followed and 70% ethanol and RNase AWAY decontaminant 
solution are used to maintain sterile RNase-free conditions. 
3.2.4 Tissue Sample Collection After Completion of Stretch Experiment 
After completion of the experiment, the stretch bioreactor system is carefully 
transferred from the CO2 incubator to the biological safety cabinet. Next, AV tissue 
samples are taken out of the bioreactor and washed three times in sterile DNase/RNase-
free ice-cold DPBS solution to remove the residual culture medium adhering to the tissues. 
Then, the portions of each tissue section connected to the springs are discarded and only 
the middle portion is kept for further analyses.  
If the tissue samples are to be used for qPCR, then each of these samples is 
transferred to an autoclaved RNase/DNase-free 2 mL microcentrifuge tube (VWR 
catalogue no. 87003-298), followed by snap-freezing using liquid nitrogen and storage in 
–80°C freezer. On the other hand, if the tissue samples are to be used for qualitative (Von 
Kossa and Alizarin Red stains) and quantitative (Arsenazo assay) assessment of 
calcification, one-third of each tissue sample (in the radial direction) is excised along the 
circumferential direction, embedded in Optimum Cutting Temperature (OCT) compound 
and stored in –80°C freezer. The remaining portion of the tissue sample is transferred to an 
autoclaved RNase/DNase-free 2 mL microcentrifuge tube, snap-frozen in liquid nitrogen 
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and stored in –80°C freezer. However, for immunostaining, the whole tissue sample is 
embedded in OCT compound and stored in –80°C freezer. 
All tools (tweezers, scalpel handle, surgical blades) and microcentrifuge tubes are 
autoclaved beforehand. Additionally, aseptic techniques are strictly followed and 70% 
ethanol and RNase AWAY decontaminant solution are used to maintain sterile RNase-free 
conditions. 
3.3 Formulations of Different Tissue Culture Media 
Two types of culture medium are used in static or stretch experiments: regular and 
osteogenic medium. The regular medium is used to maintain normal cell viability of 
porcine AV tissues over the course of an experiment, whereas the osteogenic medium is 
used to accelerate the process of AV calcification by adding specific chemicals that 
promote osteogenesis. Both media formulations were previously developed and validated 
in the Cardiovascular Fluid Mechanics Laboratory (Balachandran, 2010). 
3.3.1 Formulation of Regular Culture Medium 
The formulation of regular medium is outlined in the following table: 







or Volume in 1L 
Medium 
Dulbecco’s Modified 
Eagle’s Medium (DMEM) 
–  13.36 g/L 13.36 g 
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Table 3.2 Continued 
[THERMO FISHER 
SCIENTIFIC catalogue no. 
12100061]  
Bovine Calf Serum 
[FISHER SCIENTIFIC 
catalogue no. SH3007203] 
– 





catalogue no. S5761] 
– 3.7 g/L 3.7 g 
Ascorbic Acid [SIGMA 
ALDRICH catalogue no. 
A7631] 
10 mg/mL of 
ultrapure water 
50 mg/L 5 mL 
HEPES Buffer [FISHER 




by volume %) 
25 mL 
Non-essential Amino Acid 
Solution [SIGMA 
ALDRICH catalogue no. 
M7145] 
100x 




SCIENTIFIC catalogue no. 
SV3007901] 
100x 
1% (volume by 
volume %) 
10 mL 








The final pH of the medium is adjusted between 7.2 and 7.4 using 1N NaOH 
(SIGMA ALDRICH catalogue no. S2770) or 1N HCl (SIGMA ALDRICH catalogue no. 
H9892) while thoroughly mixing by a NuovaTM stirring hotplate (THERMO FISHER 
SCIENTIFIC). Eventually, the medium is sterile-filtered using a 0.2 µm vacuum filter unit 
(VWR catalogue no. 89216-298) and stored in 4°C fridge. It is ensured that the 1 L glass 
bottle into which the above listed components are added is autoclaved. Additionally, 
aseptic techniques are strictly followed and 70% ethanol and RNase AWAY decontaminant 
solution are used to maintain sterile RNase-free conditions. 
3.3.2 Formulation of Osteogenic Culture Medium 
The osteogenic medium is simply the regular medium supplemented with specific 
chemicals that induce osteogenic differentiation. These additional reagents, as outlined 
below, are separately added to a petri dish or each bioreactor well during setting up a static 
or stretch experiment, respectively. 












catalogue no. S369-500] 
100 mM (in 
ultrapure water) 
3.8 mM 190 µL (760 µL) 
β-Glycerophosphate 
[SIGMA ALDRICH 
catalogue no. G9422] 
100 mM (in 
ultrapure water) 
1 mM 50 µL (200 µL) 
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Table 3.3 Continued 
Dexamethasone [SIGMA 
ALDRICH catalogue no. 
D4902] 
2.5 mM (in 100% 
ethanol) 




catalogue no. T5050] 




1 ng/mL 5 µL (20 µL) 
All components are sterile-filtered using a 0.2 µm syringe filter (FISHER 
SCIENTIFIC catalogue no. 09-719C). The stock solution of sodium phosphate is stored in 
4°C fridge, whereas β-glycerophosphate and dexamethasone solutions are stored in –20°C 











3.4 Workflow for Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR) 
The detection and relative quantification of miRNA or mRNA in tissue samples is 
accomplished using RT-qPCR. The entire process is comprised of several steps, as outlined 
in the following diagram: 
Each of the above steps is described in detail in the following sections: 
3.4.1 Tissue Grinding 
Before starting the tissue grinding process, the countertop area and all the material 
surfaces that come in contact with the tissue sample are thoroughly wiped by RNase 
AWAY decontaminant solution (VWR catalogue no. 53225-514). First, porcine aortic 
valve (AV) tissue sample from static or stretch experiments is placed in a mortar (VWR 
catalogue no. 470148-960). Then, liquid nitrogen is added from a dewar flask (VWR 
catalogue no. 63415-000) to completely immerse the tissue sample inside the mortar. After 
that, a pestle (VWR catalogue no. 470148-960) is used to gradually apply a twisting 




















Figure 3.4 – Workflow diagram for RT-qPCR 
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Throughout the entire process, it is ensured that the tissue sample is always immersed in 
liquid nitrogen. 
3.4.2 Tissue Lysis 
Immediately after grinding the tissue sample to a fine powder form, more liquid 
nitrogen is added to the mortar to form a slurry-like mixture. The mixture is then transferred 
to an autoclaved RNase-free 2 mL microcentrifuge tube (VWR catalogue no. 87003-298) 
via a funnel (VWR catalogue no. 414004-269). The remaining liquid nitrogen inside the 
microcentrifuge tube evaporates within the next 5 – 10 seconds. To lyse the grinded tissue 
sample, 1500 µL of QIAzol lysis reagent (QIAGEN catalogue no. 79306) is added to the 
microcentrifuge tube using a 1000 µL pipettor (VWR catalogue no. 89079-974). During 
this step, it is ensured that the 50 – 1000 µL pipet tips (VWR catalogue no. 47745-174) 
being used are autoclaved. Subsequently, proper mixing of the powdered tissue sample and 
the lysis reagent is ensured using a vortex mixer (DADE catalogue no. S8223-1), followed 
by a static reaction time of 1 minute. Throughout the entire process, the microcentrifuge 
tube is kept on ice. After this step, the process of RNA isolation can be started right away 
or the microcentrifuge tube containing the powdered tissue sample/lysis reagent mixture 
can be stored in –80°C freezer for RNA isolation later. 
3.4.3 RNA Isolation 
Before starting the process of RNA isolation, it is ensured that the 50 – 1000 µL 
and 2 – 200 µL pipet tips (VWR catalogue no. 47745-170), and the 2 mL microcentrifuge 
tubes are autoclaved. RNA isolation is accomplished by using the Direct-zolTM RNA 
MiniPrep Plus RNA isolation kit from ZYMO RESEARCH (catalogue no. R2072).  
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First, all microcentrifuge tubes containing the powdered tissue sample/lysis reagent 
mixtures are centrifuged in a SorvallTM LegendTM Micro 21R microcentrifuge at 
13,000xg for 10 minutes. After that, the supernatant tissue lysate (almost 1500 µL) is 
collected equally into two autoclaved RNase-free 2 mL microcentrifuge tubes. Then, 750 
µL of 100% molecular biology-grade ethanol (SIGMA ALDRICH catalogue no. E7023) 
is added to each of those tubes. After thorough mixing using a vortex mixer, 750 µL of the 
mixture is transferred into a Zymo-SpinTM IIICG Column (provided in the kit) in a 
Collection Tube (provided in the kit), which is centrifuged at 13,000xg for 1 minute. The 
flow-through is subsequently discarded, and the step is repeated three more times using the 
same Spin Column and Collection Tube to elute the full 3000 µL mixture of tissue lysate 
and 100% ethanol.  
800 µL of RNA Wash Buffer (provided in the kit) is then added to the Spin Column, 
and the Spin Column-Collection Tube assembly is centrifuged at 13,000xg for 1 minute. 
After discarding the flow-through, an 80 µL mixture of DNase I and DNA Digestion Buffer 
(both provided in the kit) is added to the column using a 100 µL pipettor (VWR catalogue 
no. 89079-974), followed by an incubation period of 15 minutes at room temperature (20 
– 25°C). The mixture contains 10 µL DNase I solution and 70 µL DNA Digestion Buffer.  
Subsequently, 800 µL of Direct-zolTM RNA PreWash (provided in the kit) is 
added to the Spin Column, and the Spin Column-Collection Tube assembly is centrifuged 
at 13,000xg for 1 minute, followed by disposal of the flow-through. This step with Direct-
zolTM RNA PreWash is repeated one more time. Then, 800 µL of RNA Wash Buffer is 
added to the Spin Column, and the Spin Column-Collection Tube assembly is centrifuged 
at 13,000xg for 3 minutes to ensure complete removal of the wash buffer.  
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Following this step, the Spin Column is carefully transferred to an autoclaved 
RNase-free 2 mL microcentrifuge tube. To elute the isolated RNA, 80 µL DNase/RNase-
Free Water (provided in the kit) is directly added to the column matrix, and the Spin 
Column-Microcentrifuge Tube assembly is centrifuged at 13,000xg for 2 minutes. The spin 
column is subsequently discarded, and the flow-through collected in the microcentrifuge 
tube contains the RNA isolated from the powdered tissue sample. The total RNA 
concentration and RNA purity of the sample can be immediately quantified using a 
NanoDrop 2000/2000c UV-Vis spectrophotometer (THERMO FISHER SCIENTIFIC) or 
the RNA sample can be stored in –80°C freezer for total RNA concentration and purity 
quantification later. 
3.4.4 Total RNA Concentration and RNA Purity Quantification 
The total RNA concentration and purity of the isolated RNA from a porcine AV 
tissue sample is quantified using a NanoDrop 2000/2000c UV-Vis spectrophotometer. 
Prior to beginning the quantification process, the pedestals of the spectrophotometer are 
cleaned. To do that, 2 µL of DNase/RNase-free water is added on the surface of the bottom 
pedestal using a 2 µL pipettor (VWR catalogue no. 89079-974), and the upper pedestal arm 
is then lowered to form a liquid column. After letting it sit for approximately 2 – 3 minutes, 
the water from both the top and bottom pedestal is wiped away using kimwipes (VWR 
catalogue no. 470224-038). 
At first, a reference RNA quantification is made by adding 2 µL of DNase/RNase-
free water on the surface of the bottom pedestal, followed by lowering of the upper pedestal 
arm and clicking the Blank button in the NanoDrop program. Subsequently, the water from 
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both the top and bottom pedestal is wiped off. Then, 2 µL of RNA sample is added on the 
surface of the bottom pedestal, followed by lowering of the upper pedestal arm and clicking 
the Measure button in the NanoDrop program. The NanoDrop program gives values for 
RNA concentration (in ng/µL), 260/280 ratio (ratio of absorbance at 260 nm and 280 nm) 
and 260/230 ratio (ratio of absorbance at 260 nm and 230 nm). The 260/280 and 260/230 
ratios are primary and secondary measures, respectively, of RNA purity. In the case of 
handling multiple RNA samples at once, the system is Blanked after every 3 – 4 
measurements. Throughout the entire process, the microcentrifuge tubes containing the 
RNA samples are kept on ice. 
3.4.5 Normalization of Total RNA Concentration 
After quantification of the total RNA concentration of all samples from same-day 
static/stretch experiments, required amounts of DNase/RNase-free water are added to the 
RNA samples to normalize their RNA concentrations to the same value. The post-
normalization total RNA concentration is typically equal to that of the RNA sample which 
has the lowest total RNA concentration (among all the same-day static/stretch experiment 
samples), obtained immediately after the NanoDrop measurement. Throughout the whole 
process, the microcentrifuge tubes containing the RNA samples should be kept on ice. 
After normalization, the process of cDNA synthesis can be started right away or the RNA 
samples can be stored in –80°C freezer for cDNA synthesis later. 
3.4.6 cDNA Synthesis 
The cDNA synthesis process is different based on whether the cDNA is to be used 
for miRNA or mRNA RT-qPCR. The two distinct synthesis methods are as follows: 
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3.4.6.1 cDNA Synthesis for miRNA RT-qPCR 
In the case of miRNA, the cDNA is synthesized using the miScript II Reverse 
Transcription Kit (QIAGEN catalogue no. 218161). At first, a reverse transcription mixture 
(for one reaction) is prepared as outlined in the following table. All the necessary 
components from the kit are thawed at room temperature (20 – 25°C) and then kept on ice 
throughout the whole process. When dealing with multiple RNA samples/reactions at once, 
the total volume of the master mixture should account for 1 – 2 more reactions than the 
required number. 
Table 3.4 – Reverse transcription mixture for miRNA 
Component Required Volume [µL] 
5x miScript HiSpec Buffer 4 
10x miScript Nucleics Mix 2 
miScript Reverse Transcriptase Mix 2 
After adding all the above components into an autoclaved 2 mL microcentrifuge 
tube, the tube should be gently vortexed (for thorough mixing) using a vortex mixer (VWR 
catalogue no. 97043-562) and briefly centrifuged (for retaining residual liquid from the 
sides of the tube) in a minicentrifuge (VWR catalogue no. 10067-588). From thereon, the 
master mixture should be kept on ice. Next, 12 µL of each RNA sample is added to an 
autoclaved 0.2 mL PCR tube (VWR catalogue no. 20170-012) using a 20 µL pipettor 
(VWR catalogue no. 89079-974), followed by the addition of 8 µL master mixture. Hence, 
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the total reaction volume is 20 µL in each tube. After this, all the PCR tubes are centrifuged 
in the minicentrifuge and placed in the 96-well thermal cycler (BIORAD MyCyclerTM). 
Prior to the thermal cycling step, the PCR tubes are kept on ice all the time. The run method 
used in the thermal cycler is as follows: 
a. 1st stage: Incubation at 37°C for 1 hour 
b. 2nd stage: Incubation at 95°C for 5 minutes to inactivate miScript Reverse 
Transcriptase Mix 
c. 3rd stage: Holding stage at 4°C 
After completion of the reaction, the prepared cDNA can be used immediately for RT-
qPCR of miRNA. Alternatively, it can be stored in 4°C fridge for short term (maximum 
one week) or in –20°C/–80°C freezer for long term (several months). 
3.4.6.2 cDNA Synthesis for mRNA RT-qPCR 
For mRNA, the cDNA is synthesized using the High-Capacity cDNA Reverse 
Transcription Kit (THERMO FISHER SCIENTIFIC catalogue no. 4368814). At first, a 
reverse transcription mixture (for one reaction) is prepared as outlined in the following 
table. All the necessary components from the kit are thawed at room temperature (20 – 
25°C) and then kept on ice throughout the entire process. When dealing with multiple RNA 
samples/reactions at once, the total volume of the master mixture should account for 1 – 2 




Table 3.5 – Reverse transcription mixture for mRNA 
Component Required Volume [µL] 
10x RT Buffer 2 
25x dNTP Mix (100 mM) 0.8 
10x RT Random Primers 2 
MultiscribeTM Reverse Transcriptase 1 
After adding all the above components into an autoclaved 2 mL microcentrifuge 
tube, the tube is gently vortexed (for thorough mixing) using a vortex mixer and briefly 
centrifuged (for retaining residual liquid from the sides of the tube) in a minicentrifuge. 
From thereon, the master mixture is kept on ice. Next, 14.2 µL of each RNA sample is 
added to an autoclaved 0.2 mL PCR tube using a 20 µL pipettor, followed by the addition 
of 5.8 µL master mixture. Hence, the total reaction volume is 20 µL in each tube. After 
this, all the PCR tubes are centrifuged in the minicentrifuge and placed in the 96-well 
thermal cycler. Prior to the thermal cycling step, the PCR tubes are kept on ice all the time. 
The run method used in the thermal cycler is as follows: 
a. 1st stage: Incubation at 25°C for 10 minutes 
b. 2nd stage: Incubation at 37°C for 2 hours 
c. 3rd stage: Incubation at 85°C for 5 minutes 
d. 4th stage: Holding stage at 4°C 
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After completion of the reaction, the prepared cDNA can be used immediately for 
real-time qPCR of mRNA. Alternatively, it can be stored in 4°C fridge for short term 
(maximum one week) or in –20°C/–80°C freezer for long term (several months). 
3.4.7 RT-qPCR 
The process of RT-qPCR is different based on whether it is used for miRNA or 
mRNA detection and relative quantification. The two distinct methods are as follows: 
3.4.7.1 RT-qPCR for miRNA 
For the real-time quantitative polymerase chain reaction (RT-qPCR) in each well 
of a 96-well qPCR plate (VWR catalogue no. 82006-636) to detect and relatively quantify 
miRNA, the following mixture is prepared: 






in 20 µL Reaction 
Volume [µM] 
Required Volume 
of Stock Solution 
[µL] 
miRNA or U6 
Primer 
5 1 4 
miScript Universal 
Primer  
–  – 4 
SYBR Green 
qPCR Master Mix  
–  – 10 
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When dealing with multiple cDNA samples/reactions at once, the total volume of 
the reagent mixture should account for 1 – 2 more reactions than the required number. All 
the necessary components are thawed at room temperature (20 – 25°C) and then kept on 
ice throughout the whole process. Here, U6 small nuclear RNA is used as the housekeeping 
gene (QIAGEN catalogue no. MS00033740). The primer assay for the specific miRNA 
(forward primer) and the miScript Universal Primer (reverse primer) are obtained from 
QIAGEN (product no. 218300 and 218073, respectively). The VeriQuest SYBR Green 
qPCR Master Mix is obtained from THERMO FISHER SCIENTIFIC (catalogue no. 
756001000RXN).  
After adding all the above components into an autoclaved 2 mL microcentrifuge 
tube, the tube is gently vortexed (for thorough mixing) using a vortex mixer and briefly 
centrifuged (for retaining residual liquid from the sides of the tube) in a minicentrifuge. 
From thereon, the reagent mixture is kept on ice. In each well of the 96-well qPCR plate, 
2 µL of cDNA sample is added using a 2 µL pipettor (VWR catalogue no. 89079-974), 
followed by the addition of 18 µL of reagent mixture. Hence, the total reaction volume in 
each well is 20 µL. Each reaction is set up to have three replicates.  
After preparing all the reaction wells, the qPCR plate is covered by an optical adhesive 
film (THERMO FISHER SCIENTIFIC catalogue no. 4360954) to prevent well-to-well 
contamination and sample evaporation. Then, to collect the liquid content in each well 
without bubbles, the qPCR plate is spun at 2500 rpm for 1 minute in a PCR plate spinner 
(VWR catalogue no. 89184-608). After that, the qPCR plate is placed in the StepOnePlusTM 
Real-Time PCR System (THERMO FISHER SCIENTIFIC catalogue no. 4376600). The 
run method used in the PCR system is as follows: 
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a. Holding (initial activation) stage: Incubation at 95°C for 15 minutes 
b. Cycling stage (50 cycles): 
1. Denaturation step: Incubation at 95°C for 15 seconds 
2. Annealing step: Incubation at 55°C for 30 seconds 
3. Extension step: Incubation at 70°C for 30 seconds (real-time fluorescence 
data are acquired during this step) 
c. Melt curve stage: 
1. 1st step: Incubation at 95°C for 15 seconds 
2. 2nd step: Incubation at 60°C for 1 minute 
3. 3rd step: Incremental temperature increase (+ 0.3°C) to 95°C with a holding 
period of 15 seconds at each increment (real-time fluorescence data are 
acquired during each temperature increment of this step) 
After completion of the RT-qPCR run, the qPCR plate is discarded, and the 
resulting data (Cycle Threshold or Ct value for each reaction well) are exported from the 
.eds file (StepOnePlusTM program) to an excel file for further analysis. 
3.4.7.2 RT-qPCR for mRNA 
For the real-time quantitative polymerase chain reaction (RT-qPCR) in each well 











in 20 µL Reaction 
Volume [µM] 
Required Volume 
of Stock Solution 
[µL] 
Forward Primer 12.5 2.5 4 
Reverse Primer  12.5 2.5 4 
SYBR Green 
qPCR Master Mix  
–  – 10 
When dealing with multiple cDNA samples/reactions at once, the total volume of 
the reagent mixture should account for 1 – 2 more reactions than the required number. All 
the necessary components are thawed at room temperature (20 – 25°C) and then kept on 
ice throughout the whole process. Here, 18S ribosomal RNA is used as the housekeeping 
gene. The forward and reverse primers for 18S and all mRNAs of interest are obtained 
from INTEGRATED DNA TECHNOLOGIES.  
After adding all the above components in an autoclaved 2 mL microcentrifuge tube, 
the tube is gently vortexed (for thorough mixing) using a vortex mixer and briefly 
centrifuged (for retaining residual liquid from the sides of the tube) in a minicentrifuge. 
From thereon, the reagent mixture is kept on ice. In each well of the 96-well qPCR plate, 
2 µL of cDNA sample and 18 of µL reagent mixture are added. Hence, the total reaction 
volume in each well is 20 µL. Each reaction is set up to have three replicates.  
 48 
After preparing all the reaction wells, the qPCR plate is covered by an optical 
adhesive film to prevent well-to-well contamination and sample evaporation. Then, to 
collect the liquid content in each well without bubbles, the qPCR plate is spun at 2500 rpm 
for 1 minute in a PCR plate spinner. After that, the qPCR plate is placed in the 
StepOnePlusTM Real-Time PCR System. The run method used in the PCR system is as 
follows: 
a. Holding stage:  
1. 1st step: Incubation at 50°C for 2 minutes 
2. 2nd step: Incubation at 95°C for 5 minutes 
b. Cycling stage (50 cycles): 
1. Denaturation step: Incubation at 95°C for 3 seconds 
2. Annealing/Extension step: Incubation at 60°C for 30 seconds (real-time 
fluorescence data are acquired during this step) 
c. Melt curve stage: 
1. 1st step: Incubation at 95°C for 15 seconds 
2. 2nd step: Incubation at 60°C for 1 minute 
3. 3rd step: Incremental temperature increase (+ 0.3°C) to 95°C with a holding 
period of 15 seconds at each increment (real-time fluorescence data are 
acquired during each temperature increment of this step) 
After completion of the qPCR run, the qPCR plate is discarded and the resulting 
data (Cycle Threshold or Ct value for each reaction well) are exported from the .eds file 
(StepOnePlusTM program) to an excel file for further analysis. 
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3.4.7.3 Designing RT-qPCR Primers for mRNA 
The forward and reverse primers for a specific mRNA are designed using the NCBI 
Primer-BLAST website (https://www.ncbi.nlm.nih.gov/tools/primer-blast/). The input 
values for the most important parameters are listed in the following table: 
Table 3.8 – Primer designing protocol for mRNA 




Depends on the gene 
and the species of 
interest 
This is obtained from the NCBI Gene 
website 
(https://www.ncbi.nlm.nih.gov/gene) 















Primer must span an 
exon-exon junction 
This is the preferable option 
No preference 
This is only used when the first option 
doesn’t output any primers  




These can be found under the Advanced 







For all the other parameters, the default values are used. In any case, the designed 
primer pair is ensured to be specific for the mRNA of interest. 
3.4.8 Analysis of RT-qPCR Data 
The RT-qPCR data are analyzed using the ΔCT method. First, it is determined whether the 
standard deviation (SD) of the three Ct values of each sample reaction (housekeeping gene 
and specific miRNA or mRNA) is less than or equal to 0.5. In case it is higher than 0.5, the 
Ct value (among the three replicates) causing the high standard deviation is not considered 
for further analysis. After this, the average values of the three (or two) Ct values for each 
sample’s housekeeping gene and specific miRNA or mRNA reactions are calculated. Next, 
the miRNA or mRNA expression in each sample is determined using one of the following 
formulae as appropriate: 
𝑚𝑖𝑅𝑁𝐴 𝐸𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 =  2[(𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝐶𝑡)𝑈6 − (𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝐶𝑡)𝑚𝑖𝑅𝑁𝐴] … … (3.1) 
𝑚𝑅𝑁𝐴 𝐸𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 =  2[(𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝐶𝑡)18𝑆 − (𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝐶𝑡)𝑚𝑅𝑁𝐴] … … (3.2) 
To calculate the fold change in miRNA or mRNA expression at a specific 
experimental condition compared to the reference experimental condition (15% vs. 10% 
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stretch, for example), the miRNA or mRNA expression values for all samples at the 
specific and reference conditions are normalized by the average value of the miRNA or 
mRNA expression in all samples at the reference condition. Hence, this makes the average 
value of miRNA or mRNA expression at the reference condition 1 and that one at the 
specific condition some number X, representative of the fold change. 
3.5 Statistical Analysis 
All the statistical analyses are done using the IBM SPSS Statistics software. 
Statistically significant difference is achieved when the significance (p) value is less than 
or equal to 0.05. The first step in comparing two different groups is to check for normality 
of each data group using the Shapiro-Wilk test. If either one or both groups are not normally 
distributed (p ≤ 0.05 in the Shapiro-Wilk test), non-parametric Mann-Whitney U test is 
used for statistical comparison. On the other hand, if both groups are normally distributed 
(p > 0.05 in the Shapiro-Wilk test), independent samples t-test is used for statistical 
comparison. In this case, equal variance assumption can be made if Levene’s test gives a 
significance value greater than 0.05. 
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CHAPTER 4. SPECIFIC AIM 1 
4.1 Introduction 
It is now well established that the initiation and progression of aortic valve (AV) 
disease, as characterized by adverse remodeling of extracellular matrix (ECM) and 
calcification, are regulated in part by hemodynamic forces (Arjunon et al., 2013; 
Balachandran et al., 2011). These mechanical forces (such as hydrostatic pressure, shear 
stress, etc.) have been shown to regulate a myriad of mechanosensitive genes in AV 
(Fernández Esmerats et al., 2016; Holliday et al., 2011; Warnock et al., 2011), including 
miRNAs.  
Elevated cyclic stretch was previously found to induce abnormal ECM remodeling 
and significant calcification (Ku et al., 2006; Balachandran et al., 2009; Balachandran et 
al., 2010; Lei et al., 2017). In the recent years, a number of studies have been conducted to 
identify stretch-responsive miRNAs that regulate cellular processes related to AV 
pathogenesis, such as miR-148a-3p regulating inflammatory gene expression in aortic 
valve interstitial cells (Patel et al., 2015). As cyclic stretch is a major biomechanical feature 
of AV function, these stretch-responsive miRNAs, owing to their regulatory role in 
modulating gene expression, may possess significant therapeutic potential for the treatment 
of AV disease. 
Recent studies have identified miR-214 as one of the fibrosa-specific and oscillatory 
shear-induced miRNAs pertinent to AV disease (Rathan et al., 2016). In addition to this, 
miR-214 was found to be significantly dysregulated in calcified human aortic valves 
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compared to healthy control (Song et al., 2017; Wang et al., 2017). Therefore, it will be 
interesting to know whether cyclic stretch modulates miR-214 expression in AV at the 
physiological and pathological levels. 
4.2 Hypothesis 
The hypothesis of this specific aim is that pathologically high cyclic stretch can 
dysregulate the expression of miR-214 in AV tissues. 
4.3 Experimental Design 
The experimental design used to accomplish the goals of the first specific aim is 
described in the following sections: 
4.3.1 Experimental Conditions 
The objective of specific aim 1 was to investigate the effects of physiological and 
pathological cyclic stretch on miR-214 expression in porcine AV tissues ex vivo. In this 
study, the physiological level of cyclic stretch was 10%, whereas 15% stretch was used as 
the pathological level (Balachandran et al., 2010). These two stretch levels of 10% and 
15% are representative of the normotensive (Thubrikar, 1989) and hypertensive (Yap et 
al., 2010) conditions, respectively. Under either stretch level, the AV leaflet tissues were 
stretched at 60 cycles/minute, which is representative of the normal resting heart rate (60 




4.3.2 Experimental Duration and Choice of Culture Medium 
The following combinations of stretch duration and culture medium were used to 
study the effect of pathological cyclic stretch (15%) on miR-214 expression at the early 
and late stages of stretch-induced AV disease: 
i. Early stage of abnormal AV remodeling → cyclic stretching at 15% in regular 
medium for 48 hours (in comparison to 10% stretch) 
ii. Late stage of AV calcification → cyclic stretching at 15% in osteogenic medium 
for 1 week (in comparison to 10% stretch) 
To simulate the early, abnormal remodeling stage in AV disease compared to the 
normal counterpart, porcine AV tissue samples were cyclically stretched at 15% 
(pathological) and 10% (physiological) for 48 hours in regular culture medium. This 
specific combination of stretch duration (48 hours) and culture medium (regular) was 
previously shown to induce significant change in ECM remodeling at 15% stretch 
compared to 10% (Balachandran et al., 2009). However, no significant calcification of AV 
tissues was observed under these conditions. 
On the other hand, the late stage of AV calcification was simulated by cyclically 
stretching AV leaflet tissues at 15% for one week in osteogenic culture medium. As usual, 
cyclic stretching at 10% under the same experimental conditions represented the 
physiological counterpart. The results from these experiments showed that quantitatively, 
AV calcification is (at least) two-fold higher at 15% stretch compared to 10% in a 
statistically significant manner (as shown in Figure 4.1). 
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In addition to these, Alizarin Red and Von Kossa stains (histological stains used for 
detecting calcification or mineralization) of frozen tissue sections from the above 
Figure 4.1 – Quantitative assessment of AV calcification resulting from 
cycling stretching of porcine AV tissues in osteogenic medium for 1 week (n = 
6; ** p < 0.01). Data are presented as mean ± standard error of mean. 
Figure 4.2 – Qualitative assessment of AV calcification resulting from 
cycling stretching of porcine AV tissues in osteogenic medium for 1 week 
(F = Fibrosa, V = Ventricularis). Arrows indicate sites of calcification. 
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experiments showed the same qualitative results, as depicted in Figure 4.2. It should also 
be noted that under the pathological cyclic stretch (15%), calcification occurred 
preferentially on the fibrosa side of AV leaflet, which is the scenario in a calcified human 
aortic valve (Freeman et al., 2005; Chen et al., 2011; Rajamannan et al., 2011). 
Previously, it was shown that when porcine AV tissues were cyclically stretched at 
15% in osteogenic medium for two weeks, there was an almost six-fold increase in 
calcification compared to 10% stretch (Balachandran et al., 2010). However, due to the 
possibility of significant RNA degradation under longer culture duration, stretch 
experiments with osteogenic medium were kept limited to a culture duration of one week 
in this study. 
4.3.3 Pairing of Stretch Experiments 
Two identical stretch bioreactor systems were used to run 10% and 15% stretch 
experiments in a pairwise fashion using porcine AV tissues harvested on the same day. 
This ruled out the effect of day-to-day variability in freshly collected tissues on the tissues’ 
biological responses under 10% and 15% stretch.   
4.3.4 Sample Pooling 
For assessing the mRNA expression of ATF4, CHOP and BCL2L1 genes using 
real-time quantitative polymerase chain reaction (RT-qPCR), two stretched tissue samples 
(either 10% or 15%) were randomly pooled into one qPCR sample to increase the resulting 
total RNA concentration. So, for example, if 16 tissue samples were obtained from each of 
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the 10% and 15% stretch experiments, the resulting sample size after pooling equaled to 8 
for each case. 
4.4 Evaluation of miR-214 Expression 
The expression of miR-214 in stretched AV tissue samples was evaluated using RT-
qPCR. Here, U6 small nuclear RNA (snRNA) was used as the housekeeping gene. The 
following sections outline the results from RT-qPCR evaluation of miR-214 expression in 
porcine AV tissue samples from 2-day stretch experiments in regular medium (early stage) 
and 7-day stretch experiments in osteogenic medium (late stage). 
4.4.1 miR-214 Expression in 2-Day Stretch Experiment with Regular Medium 
For the first part of specific aim 1, freshly obtained porcine AV leaflet tissues were 
cyclically stretched at 10% and 15% in regular medium for 48 hours, as described earlier. 
Higher cyclic stretch (15%) in normal culture environment represented the abnormal 
Figure 4.3 – miR-214 expression in porcine AV tissues after cycling 
stretching in regular medium for 48 hours (n = 8; NS = non-significant). 
Data are presented as mean ± standard error of mean. 
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remodeling (early) stage of AV disease, whereas 10% stretch served as the physiological 
counterpart. After completion of the stretch experiments, the expression of miR-214 
(relative to U6) was evaluated in the stretched tissue samples using RT-qPCR. As seen in 
Figure 4.3, there is no statistically significant difference in miR-214 expression (p = 0.784) 
between 10% and 15% stretch. This may indicate that the early stage of adverse AV 
remodeling induced by elevated cyclic stretch does not evoke a significant change in miR-
214 expression. 
4.4.2 miR-214 Expression in 7-Day Stretch Experiment with Osteogenic Medium 
For the second part of specific aim 1, freshly obtained porcine AV leaflet tissues 
were cyclically stretched at 10% and 15% in osteogenic medium for one week, as described 
earlier. Higher cyclic stretch (15%) in osteogenic culture environment represented the 
calcification (late) stage of AV disease, whereas 10% stretch served as the physiological 
counterpart. After completion of the stretch experiments, the expression of miR-214 
Figure 4.4 – miR-214 expression in porcine AV tissues after cycling stretching in 
osteogenic medium for 1 week (n = 9 – 10; * p < 0.05). Data are presented as 
mean ± standard error of mean. 
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(relative to U6) was evaluated in the stretched tissue samples using RT-qPCR. As shown 
in Figure 4.4, miR-214 expression is significantly downregulated at 15% stretch compared 
to 10%. This may point toward a potentially negative correlation between miR-214 
expression and stretch-induced calcification in the late stage of AV disease. 
4.5 Summary of miR-214 RT-qPCR Results 
Porcine AV tissues were cyclically stretched for 48 hours in regular medium and for 
1 week in osteogenic medium to approximate the early remodeling and late calcification 
stages of AV disease, respectively. The expression of miR-214 was then evaluated in the 
resulting tissue samples using RT-qPCR. Figure 4.5 summarizes the RT-qPCR results for 
miR-214 expression. Stretch-induced early AV remodeling did not cause significantly 
different expression of miR-214. However, it is quite interesting to observe significantly 
Figure 4.5 – Summary of results for specific aim 1 
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downregulated expression of miR-214 under conditions of stretch-induced AV 
calcification. Similar downregulation of miR-214 expression was also found in calcified 
human aortic valves compared to healthy control (Song et al., 2017; Wang et al., 2017). 
These observations, in turn, imply a protective role of miR-214 in AV disease and loss of 
miR-214 is potentially associated with stretch-induced AV calcification. 
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CHAPTER 5. SPECIFIC AIM 2 
5.1 Introduction 
Activating Transcription Factor 4 (ATF4) is a major component of the PRKR-Like 
Endoplasmic Reticulum Kinase (PERK)-Eukaryotic Translation Initiation Factor 2α 
(eIF2α) signaling pathway, which is one of the three endoplasmic reticulum (ER) stress 
pathways (Hetz, 2012; Ron et al., 2007). These pathways significantly regulate cellular 
processes like apoptosis (Puthalakath et al., 2007), autophagy (Kouroku et al., 2006), 
inflammation (Garg et al., 2012), etc. Interestingly, ER stress has been shown to promote 
calcification in AV, in which the PERK-eIF2α-ATF4 signaling pathway plays a major role 
(Cai et al., 2013; Wang et al., 2017).  
Mechanical stretch has been found to promote inflammation and apoptosis in smooth 
muscle cells via induction of ER stress (Jia et al., 2015). Under ER stress, both transcription 
and translation of ATF4 are increased, resulting in cell death situations via upregulation of 
C/EBP-Homologous Protein (CHOP) expression (Dey et al., 2010; Han et al., 2013).  
Interestingly, ATF4 has been shown to promote mineralization in vascular smooth 
muscle cells (Masuda et al., 2013; Masuda et al., 2016), osteoblasts (Saito et al, 2011; Xiao 
et al., 2005), mesenchymal stem cells (Zhou et al., 2016; Yu et al., 2013), etc. It was also 
found that ATF4 can evoke the expression of osteoblast-specific genes in non-osteoblastic 
cells (Yang et al., 2004). On the other hand, CHOP has been shown to have a potentially 
repressive effect on the expression of pro-survival gene BCL2L1 under apoptotic 
conditions (Noh et al., 2015; Gaudette et al., 2014). 
 62 
The following diagram shows a linear path of interactions among ATF4, CHOP and 
BCL2L1 genes under stress conditions, which is adapted from the Apoptosis pathway of 
the Kyoto Encyclopedia of Genes and Genomes (KEGG) database: 
Since ATF4 has been experimentally validated to be a target of miR-214 in several 
recent studies (Wang et al., 2013; Li et al., 2015), it will be interesting to see how cyclic 
stretch modulates the expression of ATF4/CHOP/BCL2L1 genes in AV at the 
physiological and pathological levels. 
5.2 Hypothesis 
The hypothesis of this specific aim is that pathologically high cyclic stretch can 
dysregulate the expression of ATF4, CHOP and BCL2L1 genes in AV tissues. 
The anticipated effects of pathological cyclic stretch on these genes are depicted in 
the following figure: 
 
Figure 5.1 – ATF4/CHOP/BCL2L1 pathway. 
Figure 5.2 – Predicted effects of pathological cyclic stretch on ATF4, CHOP 
and BCL2L1 genes. 
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5.3 Experimental Design 
The experimental design used to accomplish the goals of the second specific aim is 
described in the following sections: 
5.3.1 Experimental Conditions 
The objective of specific aim 2 was to investigate the effects of physiological and 
pathological cyclic stretch on the mRNA expression of ATF4, CHOP and BCL2L1 genes 
in porcine AV tissues ex vivo. Therefore, as described in specific aim 1, 10% and 15% 
were used as the physiological and pathological level of cyclic stretch, respectively and 
AV leaflet tissues were stretched at 60 cycles/minute under either stretch level. 
5.3.2 Experimental Duration and Choice of Culture Medium 
As described in specific aim 1, the following combinations of stretch duration and 
culture medium were used to study the effect of pathological cyclic stretch (15%) on ATF4, 
CHOP and BCL2L1 genes at the early and late stages of stretch-induced AV disease: 
i. Early stage of abnormal AV remodeling → cyclic stretching at 15% in regular 
medium for 48 hours (in comparison to 10% stretch) 
ii. Late stage of AV calcification → cyclic stretching at 15% in osteogenic medium 
for 1 week (in comparison to 10% stretch) 
5.3.3 Pairing of Stretch Experiments 
Similar to specific aim 1, two identical stretch bioreactor systems were used to run 
10% and 15% stretch experiments in a pairwise fashion using porcine AV tissues harvested 
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on the same day. This ruled out the effect of day-to-day variability in freshly collected 
tissues on the tissues’ biological responses under 10% and 15% stretch. 
5.3.4 Sample Pooling 
For assessing the mRNA expression of ATF4, CHOP and BCL2L1 genes using 
real-time quantitative polymerase chain reaction (RT-qPCR), two stretched tissue samples 
(either 10% or 15%) were randomly pooled into one qPCR sample to increase the total 
RNA concentration. So, for example, if 16 tissue samples were obtained from each of the 
10% and 15% stretch experiments, the resulting sample size after pooling equaled to 8 for 
each case. 
5.3.5 Primer Sequences for mRNA qPCR 
The following table outlines the primer sequences of 18S (housekeeping gene), 
ATF4, CHOP and BCL2L1 that were used in RT-qPCR. As described in the Methods 
chapter, the primer pair for each mRNA was designed to be specific for the gene and 
species (pig) in question. 
Table 5.1 – Primer sequences for mRNA qPCR 
mRNA Forward Primer (5'→3') Reverse Primer (5'→3') 
18S AGGAATTGACGGAAGGGCACCA GTGCAGCCCCGGACATCTAAG 
ATF4 AGTCCTTTTCTGCGAGTGGG GAGAAGCGCCATGGCCTAAG 
CHOP CCCTGGAAATGAGGAGGAGTC TGACTGGAATCAGGCGAGTG 
BCL2L1 TGACCACCTAGAGCCTTGGA CGTCAGGAACCATCGGTTGA 
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5.4 Evaluation of ATF4, CHOP and BCL2L1 mRNA Expression 
The mRNA expression of ATF4, CHOP and BCL2L1 genes in stretched AV tissue 
samples was evaluated using RT-qPCR. As mentioned previously, 18S ribosomal RNA 
(rRNA) was used as the housekeeping gene. The following sections outline the results from 
RT-qPCR evaluation of these mRNAs in porcine AV tissue samples from 2-day stretch 
experiments in regular medium (early stage) and 7-day stretch experiments in osteogenic 
medium (late stage). 
5.4.1 mRNA Expression in 2-Day Stretch Experiment with Regular Medium 
For the first part of specific aim 2, freshly obtained porcine AV leaflet tissues were 
cyclically stretched at 10% and 15% in regular medium for 48 hours, as described earlier. 
Higher cyclic stretch (15%) in normal culture environment represented the abnormal 
remodeling (early) stage of AV disease, whereas 10% stretch served as the physiological 
Figure 5.3 – ATF4, CHOP and BCL2L1 mRNA expression in porcine AV 
tissues after cyclic stretching for 48 hours in regular medium (n = 7 – 8; * p < 
0.05; ** p < 0.01; NS = non-significant). Data are presented as mean ± standard 
error of mean. 
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counterpart. After completion of the stretch experiments, the expression of ATF4, CHOP 
and BCL2L1 mRNA (relative to 18S) was evaluated in the stretched tissue samples using 
RT-qPCR.  
As seen in Figure 5.3, ATF4 expression is significantly increased (by 38%) and 
BCL2L1 expression is significantly decreased (by 47%) at 15% stretch compared to the 
ones at 10%. However, there is no statistically significant difference (0%) in CHOP 
expression between 10% and 15% stretch. These may indicate that the early stage of 
adverse AV remodeling induced by elevated cyclic stretch evokes a significant change in 
ATF4 and BCL2L1 expression toward the expected trend (increasing and decreasing, 
respectively). Nonetheless, this increased expression of ATF4 does not cause any 
significant increase in CHOP expression at 15% stretch compared to 10%. 
5.4.2 mRNA Expression in 7-Day Stretch Experiment with Osteogenic Medium 
For the second part of specific aim 2, freshly obtained porcine AV leaflet tissues 
were cyclically stretched at 10% and 15% in osteogenic medium for one week, as described 
earlier. Higher cyclic stretch (15%) in osteogenic culture environment represented the 
calcification (late) stage of AV disease, whereas 10% stretch served as the physiological 
counterpart. After completion of the stretch experiments, the expression of ATF4, CHOP 
and BCL2L1 mRNA (relative to 18S) was evaluated in the stretched tissue samples using 
qPCR.  
As seen in Figure 5.4, there is 115% increase in ATF4 expression and 53% decrease 
in BCL2L1 expression at 15% stretch compared to 10%, which are of similar trends to 
those from 2-day stretch experiments in regular medium. However, these changes in ATF4 
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and BCL2L1 expression were not statistically significant (corresponding p-values are 
0.098 and 0.094, respectively). Additionally, the 27% increase in CHOP expression at 15% 
stretch compared to 10% was statistically non-significant (p = 0.595). These may indicate 
that AV calcification induced by elevated cyclic stretch in these experiments 
(approximating the late stage of AV disease) evokes similar trends in ATF4, CHOP and 
BCL2L1 expression compared to those in 2-day stretch experiments in regular medium. 
5.5 Summary of mRNA RT-qPCR Results 
Porcine AV tissues were cyclically stretched for 48 hours in regular medium and for 
1 week in osteogenic medium to approximate the early remodeling and late calcification 
stages of stretch-induced AV disease, respectively. The mRNA expression of ATF4, 
CHOP and BCL2L1 genes was then evaluated in the resulting tissue samples using RT-
Figure 5.4 – ATF4, CHOP and BCL2L1 mRNA expression in porcine AV tissues 
after cyclic stretching for 1 week in osteogenic medium (n = 7 – 8; NS = non-
significant). Data are presented as mean ± standard error of mean. 
 68 
qPCR. It was anticipated that elevated cyclic stretch would significantly upregulate ATF4 
and CHOP expression and downregulate BCL2L1 expression in AV tissues.  
RT-qPCR results, as summarized in Figure 5.5, showed that stretch-induced early 
AV remodeling was associated with significant upregulation of ATF4 expression and 
significant downregulation of BCL2L1 expression. However, there was zero change in 
CHOP expression between 10% and 15% stretch. Under the condition of stretch-induced 
AV calcification, mRNA expression of ATF4, CHOP and BCL2L1 genes showed identical 
trends, although statistically non-significant. Similar upregulation of ATF4 expression was 
also found in calcified human aortic valves compared to healthy control (Wang et al., 
2017), whereas downregulation of BCL2L1 expression was observed in fibrosa-specific 
human aortic valve endothelial cells (HAVECs) under oscillatory shear flow compared to 
Figure 5.5 – Summary of results for specific aim 2. 
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pulsatile shear flow (Holliday et al., 2011). These results may underlie the possible 
association of dysregulated ATF4 and BCL2L1 mRNA expression with the stretch-induced 
pathogenesis of AV disease. 
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CHAPTER 6. SPECIFIC AIM 3 
6.1 Introduction 
As described in the Specific Aim 2 chapter, ATF4 is a major component of the 
PERK-eIF2α signaling pathway, which is one of the three ER stress pathways (Hetz, 2012; 
Ron et al., 2007). ATF4 was found to promote osteogenesis in different types of cells, such 
as vascular smooth muscle cells (Masuda et al., 2016), osteoblasts (Saito et al, 2011), etc. 
Interestingly, several experimental studies have previously validated ATF4 as a target of 
miR-214 (Wang et al., 2013; Li et al., 2015). Especially, the study by Wang et al. (2013) 
showed that miR-214 inhibits bone formation by targeting ATF4. Studies by Zhao et al. 
(2015) and Li et al. (2016) pointed out the disrupting effect of miR-214 on bone 
homeostasis by promotion of osteoclastogenesis and consequent increase in bone 
resorption. Considering the facts that ER stress promotes AV calcification (Cai et al., 2013) 
and AV calcification is highly similar to the bone formation process (Rajamannan et al., 
2003), it won’t be surprising if miR-214 is found to have an inhibiting effect on AV 
calcification via downregulation of ATF4 expression. 
On the other hand, CHOP, which is one of the downstream targets of ATF4, has been 
shown to promote cell apoptosis (Oyadomari et al., 2004). It is well known that increased 
apoptosis is associated with AV calcification (Jian et al., 2003; Rajamannan et al., 2011). 
CHOP can promote apoptosis by indirectly repressing the expression of pro-survival gene 
BCL2L1 (Noh et al., 2015).  Therefore, miR-214 overexpression has the potential to 
suppress cellular apoptosis in AV disease by indirectly repressing CHOP expression via 
inhibition of ATF4 expression.  
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ATF4 is also known to transcriptionally regulate the expression of osteocalcin 
(BGLAP) (Lian et al., 2009; Yang et al., 2004), which is associated with an osteoblast 
phenotype. Since osteocalcin (BGLAP) is highly expressed in human calcified aortic valve 
(Rajamannan et al., 2003), miR-214 overexpression has the potential to suppress AV 
calcification by indirectly repressing BGLAP expression via inhibition of ATF4 
expression. The following diagram outlines the altered expression of ATF4, CHOP, 
BCL2L1 and BGLAP genes in AV calcification: 
Hence, this specific aim focuses on evaluating the effect of miR-214 overexpression 
on the mRNA expressions of ATF4, CHOP, BCL2L1 and BGLAP genes, thereby 
elucidating this miRNA’s role in apoptosis and calcification of AV tissues. 
6.2 Hypothesis 
The hypothesis of this specific aim is that miR-214 overexpression can downregulate 
the expression of ATF4, CHOP and BGLAP genes and upregulate the expression of 
BCL2L1 gene in AV tissues. 
The anticipated effects of miR-214 overexpression on these genes are depicted in the 
following figure: 
Figure 6.1 – ATF4, CHOP, BCL2L1 and BGLAP 
expression in AV calcification. 
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6.3 Experimental Design 
The experimental design used to accomplish the goals of the third specific aim is 
described in the following sections: 
6.3.1 Experimental Conditions 
The objective of specific aim 3 was to investigate the effect of miR-214 
overexpression on the mRNA expression of ATF4, CHOP, BCL2L1 and BGLAP genes. 
For this purpose, porcine AV tissues were transfected with negative control mimic and 
miR-214 mimic in static cultures. Static cultures were used to facilitate the most efficient 
transfection of AV tissues and consequent effect on mRNA expression with the mimics. 
As described in the Methods chapter, the final concentrations of both negative control 
mimic and miR-214 mimic in the static culture medium were 50 nM. 
6.3.2 Experimental Duration and Choice of Culture Medium 
The above mentioned static transfection experiments were carried out for 48 hours 
in osteogenic culture medium. A culture duration of 48 hours was deemed to be sufficient 
for the mimics to have significant effects (if any) on the mRNA expression of the genes of 
Figure 6.2 – Predicted effects of miR-214 overexpression on ATF4, CHOP, 
BCL2L1 and BGLAP genes 
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interest. On the other hand, osteogenic culture medium was used in these experiments to 
promote a calcific environment for the cultured AV tissues. 
6.3.3 Pairing of Transfection Experiments 
Static transfection experiments with negative control mimic and miR-214 mimic 
were run in a pairwise fashion using porcine AV tissues harvested on the same day. This 
ruled out the effect of day-to-day variability in freshly collected tissues on the tissues’ 
biological responses under static transfection with negative control and miR-214 mimics. 
6.3.4 Sample Pooling 
The total RNA yield from each tissue sample was quite high (total RNA 
concentration ≥ 100 ng/µL) for these static transfection experiments. Therefore, no sample 
pooling was deemed necessary. 
6.3.5 Primer Sequences for mRNA RT-qPCR 
The following table outlines the primer sequences of 18S (housekeeping gene), 
ATF4, CHOP, BCL2L1 and BGLAP that were used in real-time quantitative polymerase 
chain reaction (RT-qPCR). As described in the Methods chapter, the primer pair for each 





Table 6.1 – Primer sequences for mRNA qPCR 
mRNA Forward Primer (5'→3') Reverse Primer (5'→3') 
18S AGGAATTGACGGAAGGGCACCA GTGCAGCCCCGGACATCTAAG 
ATF4 AGTCCTTTTCTGCGAGTGGG GAGAAGCGCCATGGCCTAAG 
CHOP CCCTGGAAATGAGGAGGAGTC TGACTGGAATCAGGCGAGTG 
BCL2L1 TGACCACCTAGAGCCTTGGA CGTCAGGAACCATCGGTTGA 
BGLAP AAAGGTGCAGCCTTCGTGT AAGCCGATGTGATCAGCCAG 
6.4 Evaluation of miR-214 and mRNA Expression 
The expression of miR-214 and mRNAs (ATF4, CHOP, BCL2L1 and BGLAP) in 
statically transfected AV tissue samples was evaluated using RT-qPCR. Here, U6 small 
nuclear RNA (snRNA) and 18S ribosomal RNA (rRNA) were used as the housekeeping 
genes for miRNA and mRNA RT-qPCR, respectively. The following sections outline the 
results from RT-qPCR evaluation of miR-214 and mRNA expression in porcine AV tissue 
samples from static transfection experiments in osteogenic medium. 
6.4.1 Evaluation of miR-214 Expression 
Freshly obtained porcine AV leaflet tissues were statically cultured in osteogenic 
medium for 48 hours in the presence of negative control mimic and miR-214 mimic 
separately, as described earlier. Static transfection with miR-214 mimic at a final 
concentration of 50 nM represented the miR-214 overexpression case, whereas the one 
with negative control mimic at the same final concentration served as the control case. 
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After completion of the transfection experiments, the expression of miR-214 (relative to 
U6) was evaluated in the statically cultured tissue samples using RT-qPCR. 
As seen in Figure 6.3, static transfection with miR-214 mimic resulted in 
significantly higher expression of miR-214 (more than 100,000-fold increase) in AV leaflet 
tissues compared to the control mimic case. This, in turn, indicates that the static 
transfection protocol (as described in the Methods chapter) was proved to be effective in 
overexpressing miR-214 in porcine AV tissues. 
6.4.2 Evaluation of mRNA Expression 
Freshly obtained porcine AV leaflet tissues were statically cultured in osteogenic 
medium for 48 hours in the presence of negative control mimic and miR-214 mimic 
separately, as described earlier. Static transfection with miR-214 mimic at a final 
Figure 6.3 – miR-214 expression in porcine AV tissues after static transfection 
for 48 hours in osteogenic medium (n = 4; * p < 0.05). Data are presented as 
mean ± standard error of mean. 
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concentration of 50 nM represented the miR-214 overexpression case, whereas the one 
with negative control mimic at the same final concentration served as the control case. 
After completion of the transfection experiments, the mRNA expression of ATF4, CHOP, 
BCL2L1 and BGLAP genes (relative to 18S) was evaluated in the statically cultured tissue 
samples using RT-qPCR. 
As seen in Figure 6.4, static transfection with miR-214 mimic resulted in 38%, 25% 
and 12% decrease in mRNA expression of ATF4, CHOP and BCL2L1 genes, respectively, 
compared to the control mimic cases. However, none of these differences were statistically 
significant (p-values for ATF4, CHOP and BCL2L1 genes were 0.161, 0.396 and 0.678, 
respectively). On the other hand, the mRNA expressions of BGLAP remained practically 
the same between the control mimic and miR-214 mimic cases. These decreases in ATF4 
and CHOP expression strengthen the notion that miR-214 overexpression may have an 
Figure 6.4 – ATF4, CHOP, BCL2L1 and BGLAP mRNA expression in porcine 
AV tissues after static transfection for 48 hours in osteogenic medium (n = 7 – 8; 
NS = non-significant). Data are presented as mean ± standard error of mean. 
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inhibiting effect on these mRNAs in AV tissues. Nonetheless, these did not result into a 
downregulation of BGLAP expression with miR-214 mimic. Interestingly, the 12% 
decrease in average BCL2L1 expression upon miR-214 overexpression is contrary to the 
prediction that CHOP may negatively regulate the expression of BCL2L1. 
6.5 Summary of RT-qPCR Results from Transfection Experiments 
Porcine AV tissues were statically cultured for 48 hours in osteogenic medium with 
negative control mimic and miR-214 mimic separately. The expression of miR-214 as well 
as those of ATF4, CHOP, BCL2L1 and BGLAP mRNAs were then evaluated using RT-
qPCR. It was anticipated that miR-214 overexpression would significantly downregulate 
ATF4, CHOP and BGLAP expression and upregulate BCL2L1 expression in AV tissues. 
Figure 6.5 – Summary of results for specific aim 3. 
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RT-qPCR results (Figure 6.5) showed that static transfection with miR-214 mimic 
caused significant upregulation of miR-214 expression in porcine AV tissues compared to 
the control mimic case. miR-214 overexpression resulted in 38%, 25% and 12% decrease 
in mRNA expression of ATF4, CHOP and BCL2L1 genes with no statistical significance. 
On the other hand, BGLAP expressions were found to be effectively the same between the 
control mimic and miR-214 mimic cases. These observations may underlie the possible 
inhibiting effect of miR-214 on the ATF4/CHOP pathway in AV tissues, thereby indicating 





CHAPTER 7. DISCUSSIONS 
7.1 Discussion of Specific Aim 1 Results 
As described in Specific Aim 1 chapter, 2-day 15% stretch in regular medium, which 
represents stretch-induced early remodeling stage of AV disease, did not exhibit 
statistically significant difference in miR-214 expression compared to the physiological 
counterpart (2-day 10% stretch in regular medium). However, 7-day 15% stretch in 
osteogenic medium, which represents stretch-induced late calcification stage of AV 
disease, showed statistically significant decrease in miR-214 expression compared to the 
physiological counterpart (7-day 10% stretch in osteogenic medium). The possible reasons 
behind these results are discussed in the following sections: 
7.1.1 Why didn’t miR-214 expression significantly change at the stretch-induced early 
remodeling stage of AV disease? 
It is intriguing to observe no significant change in miR-214 expression at the 
stretch-induced early remodeling stage of AV disease (2-day 15% stretch in regular 
medium) compared to the physiological counterpart (2-day 10% stretch in regular 
medium). miR-214 transcription is positively regulated by TWIST1, a basic helix-loop-
helix (bHLH) transcription factor (Lee et al., 2009). TWIST1 expression was previously 
shown to be induced by TIMP1 (Tissue Inhibitor of Metalloproteinases 1) (D’Angelo et 
al., 2014). TIMP1, along with MMP2 (Matrix Metalloproteinase 2), are major indicators 
of adverse extracellular matrix (ECM) remodeling in AV disease (Kaden et al., 2004; 
Kaden et al., 2005; Balachandran et al. 2009). 
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Interestingly, Balachandran et al. (2009) showed using porcine AV tissues that 
there was no statistically significant difference in TIMP1 expression between 10% and 
15% stretch after 2 days of cyclic stretching in regular medium, although the expression of 
MMP2 showed significant increase at 15% stretch compared to 10%. Consequently, similar 
TIMP1 expression under both stretch levels implies that there may be no significant change 
in TWIST1 expression, justifying the observed non-significant difference in miR-214 
expression at the stretch-induced early remodeling stage of AV disease.  
Therefore, considering all these evidences, it can be concluded that miR-214 is not 
associated with stretch-induced adverse AV remodeling. Furthermore, it can be 
hypothesized that non-significant change in TWIST1 expression may be responsible for 
the non-significant difference in miR-214 expression observed during stretch-induced 
adverse AV remodeling. 
7.1.2 Why was miR-214 expression significantly downregulated at the stretch-induced 
late calcification stage of AV disease? 
It is highly interesting to observe significant downregulation of miR-214 expression 
at the stretch-induced late calcification stage of AV disease (7-day 15% stretch in 
osteogenic medium) compared to the physiological counterpart (7-day 10% stretch in 
osteogenic medium). Similar downregulation of miR-214 expression was also found in 
calcified human aortic valves compared to healthy control (Song et al., 2017; Wang et al., 
2017). Together, these results imply a negative correlation between miR-214 expression 
and AV calcification. This implication can be further corroborated by the inhibiting effect 
of miR-214 on osteogenic differentiation of osteoblasts (Wang et al., 2013; Zhao et al., 
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2015; Li et al., 2016), myoblasts (Shi et al., 2013), mesenchymal stem cells (Yang et al., 
2016), etc. 
As mentioned previously, TWIST1, a basic helix-loop-helix (bHLH) transcription 
factor, is a positive regulator of miR-214 transcription (Lee et al., 2009). Interestingly, 
TWIST1 expression was found to be significantly downregulated in calcified human aortic 
valves compared to healthy control (Zhang et al., 2014; Zhu et al., 2016). In addition to 
that, TWIST1 has an inhibiting effect on the osteogenic differentiation of aortic valve 
interstitial cells (Zhang et al., 2014; Zhu et al., 2016), osteoblasts (Bialek et al., 2004), 
mesenchymal stem cells (Miraoui et al., 2010), etc.  
From a biomechanics point of view, elevated cyclic stretch (15%) over a long 
culture duration (much greater than 48 hours) can downregulate TWIST1 expression via 
downregulation of its positive regulator, Scleraxis (SCX), another basic helix-loop-helix 
(bHLH) transcription factor, compared to 10% stretch (Morita et al., 2013; Roche et al., 
2016; Bagchi et al., 2016).  
Therefore, considering all these evidences, it can be concluded that miR-214 has a 
protective role in stretch-induced AV calcification. Furthermore, it can be hypothesized 
that downregulation of TWIST1 expression may be responsible for the downregulation of 






7.1.3 Do stretch and shear regulate miR-214 expression in AV similarly? If not, why? 
Previous studies have established that both low magnitude (± 5 dyne/cm2 peak 
value and 1 Hz frequency) and high magnitude (± 25 dyne/cm2 peak value and 1 Hz 
frequency) oscillatory shear stress, when applied to the fibrosa side of porcine AV in an 
osteogenic environment, induce higher AV calcification compared to the physiological 
oscillatory shear stress (± 10 dyne/cm2 peak value and 1 Hz frequency) (Rathan et al., 
2011). In addition to that, Rathan et al. (2016) assessed miR-214 expression in porcine AV 
tissues under the following conditions: 
i. FPS: Fibrosa exposed to unidirectional pulsatile shear stress (79 dyne/cm2 peak 
value and 1 Hz frequency) 
Figure 7.1 – miR-214 in stretch-induced AV calcification. 
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ii. FOS: Fibrosa exposed to low magnitude oscillatory shear stress (± 5 dyne/cm2 peak 
value and 1 Hz frequency) 
iii. VPS: Ventricularis exposed to unidirectional pulsatile shear stress (79 dyne/cm2 
peak value and 1 Hz frequency) 
iv. VOS: Ventricularis exposed to low magnitude oscillatory shear stress (± 5 
dyne/cm2 peak value and 1 Hz frequency) 
It was found that FOS condition significantly upregulates miR-214 expression in 
AV compared to each of the other three conditions, as outlined in the following diagram: 
At this point, it should be noted that the low magnitude oscillatory shear stress (± 
5 dyne/cm2 peak value and 1 Hz frequency) is representative of the bidirectional oscillatory 
shear stress experienced by the fibrosa side of a diseased AV, whereas the unidirectional 
pulsatile shear stress (79 dyne/cm2 peak value and 1 Hz frequency) is representative of the 
pulsatile shear stress experienced by the ventricularis side of a normal AV (Rathan et al., 
2016; Yap et al., 2012; Yap et al., 2012; Rathan et al., 2011; Ge et al., 2009; Cao et al., 
2016). 
Since the fibrosa and ventricularis side of AV (whether healthy or diseased) 
experiences bidirectional oscillatory shear stress and unidirectional pulsatile shear stress, 
respectively (Ge et al., 2009), the abovementioned comparisons of miR-214 expression are 
Figure 7.2 – Shear stress and miR-214 expression in AV (Rathan et al., 2016). 
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debatable from a physiological perspective. Considering that exposure of fibrosa to either 
sub-physiological (± 5 dyne/cm2 peak value and 1 Hz frequency) or supra-physiological (± 
25 dyne/cm2 peak value and 1 Hz frequency) oscillatory shear stress causes higher AV 
calcification compared to the physiological oscillatory shear stress (± 10 dyne/cm2 peak 
value and 1 Hz frequency) (Rathan et al., 2011), the more realistic conditions, using a 
single-sided cone-and-plate shear system (Sucosky et al., 2008), are listed below: 
i. Fibrosa exposed to physiological oscillatory shear stress (± 10 dyne/cm2 peak value 
and 1 Hz frequency) 
ii. Fibrosa exposed to sub-physiological oscillatory shear stress (± 5 dyne/cm2 peak 
value and 1 Hz frequency) 
iii. Fibrosa exposed to supra-physiological oscillatory shear stress (± 25 dyne/cm2 peak 
value and 1 Hz frequency) 
In case of a double-sided cone-and-plate shear system (Sun et al., 2011), the more 
realistic conditions, following the approach of Sun et al. (2013), are listed below: 
i. Fibrosa exposed to physiological oscillatory shear stress (~ ± 10 dyne/cm2 peak 
value and 1 Hz frequency) and ventricularis exposed to physiological pulsatile 
shear stress (~ 80 dyne/cm2 peak value and 1 Hz frequency) simultaneously 
ii. Fibrosa exposed to sub-physiological oscillatory shear stress (~ ± 5 dyne/cm2 peak 
value and 1 Hz frequency) and ventricularis exposed to sub-physiological pulsatile 
shear stress (~ 40 dyne/cm2 peak value and 1 Hz frequency) simultaneously 
iii. Fibrosa exposed to supra-physiological oscillatory shear stress (~ ± 20 dyne/cm2 
peak value and 1 Hz frequency) and ventricularis exposed to supra-physiological 
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pulsatile shear stress (~ 160 dyne/cm2 peak value and 1 Hz frequency) 
simultaneously 
Especially, Sun et al. (2013) showed that the supra-physiological case [condition 
(iii) above] with porcine AV resulted in significantly higher expression of Bone 
Morphogenetic Protein-4 (BMP-4), Transforming Growth Factor-β1 (TGF-β1), Matrix 
Metalloproteinase-2 and -9 (MMP-2 and -9), and Cathepsin-L and -S compared to the 
physiological case [condition (i) above]. However, there was no significant difference in 
these genes’ expression between the sub-physiological [condition (ii) above] and the 
physiological case [condition (i) above]. 
Mahler et al. (2014) reported that when porcine aortic valve endothelial cells 
(PAVECs) were exposed to low (± 2 dyne/cm2 peak value and 1 Hz frequency), moderate 
(± 10 dyne/cm2 peak value and 1 Hz frequency) and high (± 20 dyne/cm2 peak value and 
1 Hz frequency) oscillatory shear stress, there was no significant difference in the 
expression of endothelial-to-mesenchymal transformation (EndMT) related genes 
(PECAM, ACTA2, Snail and TGF-β1). Since TWIST1 is an EndMT gene and a positive 
regulator of miR-214 transcription (Lee et al., 2009), similar non-significant difference in 
miR-214 expression can be expected when AV fibrosa is exposed to sub-physiological (~ 
± 5 dyne/cm2 peak value and 1 Hz frequency), physiological (~ ± 10 dyne/cm2 peak value 
and 1 Hz frequency) and supra-physiological (~ ± 20 dyne/cm2 peak value and 1 Hz 
frequency) oscillatory shear stress for 48 hours. This expectation is also strengthened by 
the regulatory relation between miR-214 and Snail expression (Lv et al., 2017), in addition 
to the fact that Snail has an inhibiting effect on osteogenic differentiation (Park et al., 2010) 
like TWIST1. 
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7.2 Discussion of Specific Aim 2 Results 
As described in Specific Aim 2 chapter, 2-day 15% stretch in regular medium, which 
represents stretch-induced early remodeling stage of AV disease, exhibited statistically 
significant increase in ATF4 expression and decrease in BCL2L1 expression compared to 
the physiological counterpart (2-day 10% stretch in regular medium). In addition to that, 
7-day 15% stretch in osteogenic medium, which represents stretch-induced late 
calcification stage of AV disease, showed identical trends (although non-significant) in 
ATF4 and BCL2L1 expression compared to the physiological counterpart (7-day 10% 
stretch in osteogenic medium). For both stages, CHOP expression was effectively the same 
between 10% and 15% stretch. The possible reasons behind these results are discussed in 
the following sections: 
7.2.1 Why was ATF4 expression upregulated and BCL2L1 expression downregulated at 
the stretch-induced early remodeling and late calcification stages of AV disease? 
It is highly interesting to observe upregulation of ATF4 expression and 
downregulation of BCL2L1 expression at the stretch-induced early remodeling (2-day 15% 
stretch in regular medium) and late calcification (7-day 15% stretch in osteogenic medium) 
stages of AV disease compared to the respective physiological counterparts (2-day 10% 
stretch in regular medium and 7-day 10% stretch in osteogenic medium). Similar 
upregulation of ATF4 expression was also found in calcified human aortic valves 
compared to normal ones (Wang et al., 2017). On the other hand, Balachandran et al. (2009) 
showed that pathological cyclic stretch (15%) induces significant increase in cell apoptosis 
(as determined by TUNEL staining) of porcine AV tissues compared to the physiological 
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level (10%), which is consistent with the observed downregulation of pro-survival 
BCL2L1 gene at 15% stretch (Finucane et al., 1999).  
It has been well established that ATF4 is a pro-osteogenic transcription factor 
(Masuda et al., 2016; Cai et al., 2013; Masuda et al., 2013; Yang et al., 2004). Valentine et 
al. (2017) showed that exposure of mouse (20 months-old) type II alveolar epithelial cells 
(ATII) to 15% cyclic stretch (at 0.86 Hz) resulted in significant increase of ATF4 
expression compared to static control. Yang et al. (2016) reported that 10% cyclic stretch 
(at 0.5 Hz) significantly upregulated ATF4 expression in human periodontal ligament cells 
(hPDLCs) compared to static control. Since elevated cyclic stretch (15%) induces higher 
AV calcification compared to the physiological level (10%) (Specific Aim 1 chapter and 
Balachandran et al., 2010), the observed upregulation of ATF4 expression (15% vs. 10% 
stretch) in porcine AV tissues makes sense from both biomechanical and functional point 
of view.  
ATF4 can upregulate the expression of MMP2 and MMP9 in cancer cells (Zhu et 
al., 2014; Dey et al., 2015; Liu et al., 2010). Similar upregulation of MMP2 and MMP9 
expression was observed in porcine AV tissues under pathological cyclic stretch (15%) 
compared to the physiological level (10%) (Balachandran et al., 2009). Additionally, ATF4 
has been shown to be a positive regulator of autophagy (B’chir et al., 2013; Matsumoto et 
al., 2013). This is interesting because autophagic cell death has been proposed to be the 
main cell death mechanism in AV calcification (Somers et al., 2006; Mistiaen et al., 2006; 
Mistiaen, 2012). On the other hand, ATF4 has been found to be essential for the 
proliferation of different types of cells, such as chondrocytes (Wang et al., 2009), 
osteoblasts (Zhang et al., 2008), tumor cells (Ye et al., 2010), etc. This is especially 
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important since pathological cyclic stretch (15%) causes significant increase in cell 
proliferation (as determined by BrdU staining) of porcine AV tissues compared to the 
physiological level (10%) (Balachandran et al., 2009). 
ATF4 is a major component of the PERK-eIF2α ER stress pathway (Xu et al., 2005; 
Wang et al., 2014). Upregulation of ATF4 expression is mediated by the sequential 
phosphorylation of PERK and eIF2α under ER stress conditions (Ron et al., 2007; Walter 
et al., 2011). Interestingly, higher degree of PERK and eIF2α phosphorylation and ATF4 
expression have been observed in calcified human aortic valves compared to normal 
control (Cai et al., 2013; Wang et al., 2017). Therefore, it can be hypothesized that increase 
in ATF4 expression during the stretch-induced early remodeling and late calcification 
stages of AV disease may be potentiated by the sequential phosphorylation of PERK and 
eIF2α (as shown in Figure 7.3). 
 
Figure 7.3 – ATF4 in stretch-induced AV remodeling and calcification. 
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As mentioned earlier, BCL2L1 is mainly a pro-survival gene (Shimizu et al., 1994; 
Kovalovich et al., 2001) due to its predominant anti-apoptotic isoform, BCL-XL 
(Gonzalez-Garcia et al., 1994; Xerri et al., 1996; Taylor et al., 1999; Bai et al., 2005). 
Downregulation of BCL2L1 expression has been shown to be associated with increased 
cell apoptosis (Hagenbuchner et al., 2010). In addition to that, decreased BCL2L1 
expression may initiate and/or stimulate autophagy (Lindqvist et al., 2014; Kim et al., 2014; 
Maejima et al., 2013; Han et al., 2011), which is consistent with the pro-autophagic effect 
of increased ATF4 expression (B’chir et al., 2013; Matsumoto et al., 2013). This is 
especially interesting since downregulation of BCL2L1 expression may result in 
autophagic cell death (Yanagisawa et al., 2003).  
B-Cell Lymphoma/Leukemia 11B (BCL11B) is a pro-survival gene (Wakabayashi 
et al., 2003) that has been shown to be a positive regulator of BCL2L1 expression 
(Grabarczyk et al., 2007; Kamimura et al., 2007). Furthermore, BCL11B expression has 
been found to be downregulated with increased arterial stiffness (Valisno et al., 2017; Al 
Maskari et al., 2016; Wu et al., 2014; Mitchell et al., 2012). Therefore, it can be 
hypothesized that decrease in BCL2L1 expression during the stretch-induced early 
remodeling and late calcification stages of AV disease may be mediated by downregulation 
of BCL11B expression (as shown in Figure 7.4).  
Interestingly, both BCL11B and BCL2L1 expression was found to be upregulated in 
calcified human aortic valves compared to normal control (Li et al., 2017; Bossé et al., 
2009), which is counterintuitive. This may indicate the occurrence of autophagy inhibition 
and associated increase in calcification during the very late stage of AV disease (Deng et 
al., 2017; Peng et al., 2017; Dai et al., 2013). 
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7.2.2 Why did CHOP expression remain effectively the same at the stretch-induced early 
remodeling and late calcification stages of AV disease? 
It is surprising to observe that CHOP expression remains effectively the same at 
the stretch-induced early remodeling (2-day 15% stretch in regular medium) and late 
calcification (7-day 15% stretch in osteogenic medium) stages of AV disease compared to 
the respective physiological counterparts (2-day 10% stretch in regular medium and 7-day 
10% stretch in osteogenic medium). However, CHOP expression was found to be 
significantly upregulated in calcified human aortic valves compared to healthy control 
(Wang et al., 2017; Cai et al., 2013). In addition to that, CHOP has been shown to promote 
both valvular and vascular calcification (Masuda et al., 2013; Cai et al., 2017).  
Figure 7.4 – BCL2L1 in stretch-induced AV remodeling and calcification. 
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Jia et al. (2017) and Jia et al. (2015) reported that cyclic stretch of 18% significantly 
upregulates CHOP expression in mouse aortic smooth muscle cells (SMCs) compared to 
static control. However, Cheng et al. (2008) showed that 20% stretch induced a brief 
(during the culture period from 12 to 18 hours) increase in CHOP expression of vascular 
smooth muscle cells (VSMCs) compared to 10% stretch, which was attenuated afterwards 
(culture period > 18 hours). Therefore, it is possible that pathological cyclic stretch (15%) 
induces similar transient increase of CHOP expression in porcine AV tissues compared to 
the physiological level (10%), which is later attenuated by some adaptive response of the 
tissue itself. 
Tribbles Homolog 3 (TRB3) is one of the transcriptional targets of both ATF4 and 
CHOP (Ohoka et al., 2005; Han et al., 2013). It should be noted here that CHOP, itself, is 
another transcriptional target of ATF4. Interestingly, increased TRB3 expression works in 
a negative feedback loop to inhibit the transcriptional induction of CHOP (Jousse et al., 
2007). In addition to that, 20% cyclic stretch has been shown to upregulate TRB3 
expression in rat cardiomyocytes compared to 10% stretch, which results in increased cell 
apoptosis (Cheng et al., 2015). TRB3 was also found to promote osteogenic differentiation 
(Zhang et al., 2017; Fan et al., 2016; Park et al., 2009) and to be positively regulated by 
TWIST1 (Lee et al., 2011).  
Therefore, it can be hypothesized that the insensitivity of CHOP expression to 
pathological cyclic stretch (15%) during the stretch-induced early remodeling and late 
calcification stages of AV disease may be caused by TRB3-mediated inhibition of its 
transiently increased expression at 15% stretch compared to 10%, whereas increased TRB3 
expression promotes adverse AV remodeling and calcification (as shown in Figure 7.5). 
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7.3 Discussion of Specific Aim 3 Results 
As described in Specific Aim 3 chapter, application of miR-214 mimic significantly 
upregulated miR-214 expression in statically cultured porcine AV tissues. However, this 
didn’t result in significant inhibition of the mRNA expression of ATF4, CHOP and 
BGLAP genes. Nonetheless, the resulting mRNA expression of ATF4 and CHOP genes 
exhibited decreasing trends, as expected (38% and 25% decrease, respectively), while the 
mRNA expression of BGLAP was literally unaffected. Additionally, transfection of 
porcine AV tissues with miR-214 mimic resulted in a slight decrease (12%) of pro-survival 
Figure 7.5 – CHOP in stretch-induced AV remodeling and calcification. 
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gene BCL2L1 expression, which was opposite to the anticipated effect. One of the 
implications of the observed results is that the used concentration of miR-214 mimic (50 
nM) may not be sufficient and higher concentration (such as 100 nM) may have to be used 
to induce significant effects on the mRNA expression of ATF4, CHOP, BCL2L1 and 
BGLAP genes.  
The most prominent effect of miR-214 mimic was on the mRNA expression of ATF4 
gene (38% decrease with a p-value of 0.161). Since ATF4 is a validated target of miR-214 
(Wang et al., 2013), application of miR-214 mimic should be able to inhibit its expression 
(whether mRNA or protein). Interestingly, it was found that miR-214 mimic inhibits ATF4 
expression in mouse osteoblasts only at the protein level (Wang et al., 2013). Therefore, it 
is a possibility that miR-214 may inhibit the expression of ATF4 gene more efficiently at 
the protein level. Subsequently, it may be able to indirectly inhibit the protein expression 
of CHOP and BGLAP genes. 
7.4 Limitations of the Study 
The research work presented in this dissertation has some limitations. These 
limitations are outlined as follows: 
i. The ex vivo stretch bioreactor applies uniaxial stretch in the circumferential 
direction. This is in contrary to the in vivo condition since AV leaflets undergo 
biaxial stretching, with ~ 10% stretch in the circumferential direction and ~ 30% 
stretch in the radial direction. However, preliminary work in our laboratory showed 
that application of 30% cyclic stretch in the radial direction does not induce 
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significant changes in the collagen and sulfated glycosaminoglycan (sGAG) 
content of AV (Balachandran, 2010). 
ii. There may be biological variability among porcine AV tissues collected on the 
same day. This is due to the inter-animal and intra-animal differences in AV tissue 
properties. The effect of this variability was nullified by always running 10% and 
15% stretch or negative control and miR-214 mimic experiments in a pairwise 
fashion. Additionally, there may be day-to-day variability among porcine AV 
tissues. To counteract this, AV tissue samples collected on (at least) two separate 
days were used for each group in a comparison case. 
iii. In specific aim 3, static cultures of porcine AV tissues were used in the transfection 
experiments, which contrasts with the dynamic AV function in vivo. However, 
these static transfection experiments were justified as the main objective was to see 




CHAPTER 8. CONCLUSIONS AND FUTURE WORKS 
This thesis work demonstrated, for the first time, the effect of physiological and 
pathological cyclic stretch on miR-214 expression in porcine AVs. It also showed that the 
expression of ATF4 gene, which is a target of miR-214, is stretch-sensitive. The key 
findings from this research work can be outlined as follows: 
• Pathological cyclic stretch downregulates miR-214 expression in AV, especially in 
the late stage of stretch-induced AV calcification. 
• Pathological cyclic stretch upregulates ATF4 expression and downregulates 
BCL2L1 expression in both the early remodeling stage and late calcification stage 
of stretch-induced AV disease. 
• Pathological cyclic stretch does not affect CHOP expression in AV. 
• miR-214 overexpression has the potential to significantly inhibit ATF4 expression 
in AV. 
 
Figure 8.1 – Proposed pathway involving stretch/miR-214/ATF4/BCL2L1. 
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Figure 8.1 represents the proposed functional pathway via which pathological 
cyclic stretch may regulate the expression of miR-214 and its target gene ATF4 in AV, 
potentially leading to increased cell death and AV calcification. To validate this proposed 
pathway, the following future works are suggested: 
• It will be interesting to see whether pathological cyclic stretch exerts similar effects 
on the mRNA and protein expression of ATF4, CHOP and BCL2L1 genes in 
porcine AV tissues. Therefore, western blotting and immunostaining of stretched 
tissue samples can be completed for assessing the protein expression of ATF4, 
CHOP and BCL2L1 genes. 
• Mechanical stretch mainly affects the interstitial cells (ICs) in AV. Hence, from a 
cellular point of view, it will be worthwhile to evaluate the effect of cyclic stretch 
on the mRNA and protein expression of ATF4, CHOP and BCL2L1 genes in 
valvular interstitial cells (VICs). In addition to that, the expression of miR-214 
should be assessed in cyclically stretched VICs. 
• The current research work evaluated the effect of miR-214 mimic on the mRNA 
expression of ATF4, CHOP, BCL2L1 and BGLAP genes in statically cultured AV 
tissues. Similar assessment of the effect of miR-214 overexpression on the mRNA 
and protein expression of above-mentioned genes needs to be completed with 
stretched tissue samples. 
• The functional effect of miR-214 on the mRNA and protein expression of ATF4, 
CHOP, BCL2L1 and BGLAP genes can be further validated by evaluating the 
effect of anti-miR-214 on these genes in static and stretched tissue samples. 
Identical functional studies can also be carried out with static and cyclically 
stretched VICs. 
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• miR-214 mimic and anti-miR-214 can be used to elucidate the effect of miR-214 
on cellular processes (such as apoptosis and proliferation) in VICs and AV tissues, 
under both static and stretch conditions. 
• The current research work did not assess the inter-dependency of ATF4, CHOP and 
BCL2L1 genes in AV tissues. Therefore, adenoviral vector (for overexpression) 
and siRNA (for inhibition of expression) based approaches can be implemented to 
assess the inter-dependency of ATF4, CHOP and BCL2L1 genes in VICs and AV 
tissues, under both static and stretch conditions. 
• The adenoviral vector and siRNA based approached can similarly be used to 
evaluate the effect of ATF4, CHOP and BCL2L1 genes on apoptosis, proliferation 
and calcification of VICs and AV tissues. 
• TWIST1 is a positive regulator of miR-214 (Lee et al., 2009). Therefore, adenoviral 
vector mediated overexpression and siRNA mediated inhibition of TWIST1 can be 
used to validate this regulatory role in static and cyclically stretched VICs and AV 
tissues. 
Together, these future works will enhance the current understanding of stretch-




A.1 Stretch Programs (Si ProgrammerTM Software) 
 
(a) 10% stretch program 
(b) 15% stretch program 
Figure A.1: Stretch programs 
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A.2 Calcium Arsenazo Assay 
A.2.1 Reagents: 
• DPBS (THERMO FISHER SCIENTIFIC catalog no. 21600044) 
• Acetic Acid 1 M (SIGMA ALDRICH catalog no. AX0073) 
• Arsenazo III Reagent (POINTE SCIENTIFIC catalog no. C7529) 
• Calcium Standard (0.5 mg/mL) (RICCA CHEMICAL COMPANY catalog no. 
1799-16) 
A.2.2 Procedure: 
1. Measure the empty weight of each microcentrifuge tube. 
2. Wash tissue samples three times with DPBS. 
3. Use mortar and pestle to grind the tissue samples with liquid nitrogen and transfer 
each of these to a microcentrifuge tube. 
4. Measure the combined weight of each microcentrifuge tube containing a wet tissue 
sample. 
5. Incubate the tissue samples in a dryer at 37°C for 24 hours. Remember to keep the 
lids of the microcentrifuge tubes open. 
6. Measure the combined weight of each microcentrifuge tube containing a dry tissue 
sample. 
7. Add 500 µL of 1 M acetic acid to each microcentrifuge tube. 
8. Vortex the tissue samples overnight (12 hours) in refrigerator. 
9. Centrifuge the samples at 13,000xg for 10 minutes.  
10. Transfer the supernatants to new microcentrifuge tubes. 
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11. Prepare calcium standards in 1 M acetic acid (0, 20, 40, 60, 80, 100 µg/mL). 
12. Pipet 25 μL of each standard and sample in triplicate to a clear 96-well plate. 
13. Add 300 μL of Arsenazo III reagent to each well (dilute sample if color change is 
more than that of maximum calcium standard). 
14. Incubate for 30 seconds at room temperature. 
15. Read the absorbance of each well in a plate reader at 650 nm (color is stable for 30 
minutes). 
A.3 Alizarin Red Stain 
A.3.1 Reagents: 
• For Alizarin Red Solution 
• Alizarin Red S 2 g (SIGMA ALDRICH catalog no. A5533) 
• DI water 100 mL 
• 0.5% Ammonium Hydroxide (SIGMA ALDRICH catalog no. 320145) 
Mix the solution, adjust the pH to 4.1 – 4.3 using 0.5% Ammonium Hydroxide. The pH 
is critical. Make fresh. 
A.3.2 Procedure: 
1. Rehydrate frozen sections in 70% ethanol. 
2. Rinse with DI water at room temperature. 
3. Incubate with Alizarin Red S solution for 30 seconds. 
4. Shake off excess dye and blot sections using Kimwipes. 
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5. Dehydrate the slides in the autostainer. 
6. Coverslip the slides and store at room temperature. 
A.4 Von Kossa Stain 
A.4.1 Reagents: 
For 5% Silver Nitrate Solution (Stable for 1 year): 
• Silver Nitrate 25 g (SIGMA ALDRICH catalog no. S8157) 
• DI water 500 mL 
Mix well, pour into a clean brown bottle and store in refrigerator at 4°C. 
For 5% Sodium Thiosulfate (Make fresh): 
• Sodium Thiosulfate 5 g (SIGMA ALDRICH catalog no. S7026) 
• DI water 100 mL 
For Nuclear Fast Red (Kernechtrot) Solution: 
• Nuclear Fast Red 0.1 g (SIGMA ALDRICH catalog no. 229113) 
• Aluminum Sulfate 5 g (SIGMA ALDRICH catalog no. 368458) 
• DI water 100 mL 
• Thymol 1 grain (SIGMA ALDRICH catalog no. T0501) 
Dissolve aluminum sulfate in DI water. Add Nuclear Fast Red and slowly heat to boil and 
cool. Filter and add a grain of thymol as a preservative. 
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A.4.2 Procedure: 
1. Rehydrate frozen sections in DI water at room temperature. 
2. Incubate slides with 5% silver nitrate solution placed under a UV lamp. Place foil 
or mirror beneath the jar/tray to reflect the light. Leave for 1 hour or until calcium 
turns black.  
3. Wash three times with DI water for 5 minutes at room temperature. 
4. Wash one time with 5% sodium thiosulfate for 5 minutes at room temperature. 
5. Wash one time with tap water, one time with DI water. 
6. Incubate slides with Nuclear Fast Red for 5 minutes at room temperature. 
7. Wash briefly with DI water. 
8. Dehydrate the slides in the autostainer. 










A.5 Raw Data 
A.5.1 Specific Aim 1 
Table A.1 – Calcification of Porcine AV Tissues under Cyclic Stretch 
Quantification of AV Calcification (Determined by Arsenazo Assay) 
Wet Basis (µg Ca/mg wet tissue) Dry Basis (µg Ca/mg dry tissue) 
10% (n = 6) 15% (n = 6) 10% (n = 6) 15% (n = 6) 
1.2325 1.6414 12.9534 14.9262 
0.2177 1.2528 3.5781 11.9958 
0.5118 1.7425 6.0766 21.7276 
0.9913 1.0992 14.1118 12.7887 
0.2442 1.3216 3.4662 15.2247 
0.1309 1.3602 2.0088 15.7760 
Table A.2 – miR-214 Expression in Stretched Porcine AV Tissues 
miR-214 Expression Relative to U6 (Determined by qPCR) 
2-Day Stretch in Regular Medium 7-Day Stretch in Osteogenic Medium 
10% (n = 8) 15% (n = 8) 10% (n = 9) 15% (n = 10) 
1.2713 2.0131 2.0682 0.6409 
1.3465 1.8832 1.4208 0.1765 
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1.4352 1.4960 0.9370 0.4888 
2.05 1.5816 0.5601 0.0789 
0.5233 0.2272 0.5579 0.3547 
0.5045 0.1958 1.9454 0.3685 
0.5279 0.1343 0.2685 0.1212 
0.3411 1.2596 0.7248 0.2153 
_ _ 0.5174 0.3181 











A.5.2 Specific Aim 2 
Table A.3 – ATF4 mRNA Expression in Stretched Porcine AV Tissues 
ATF4 mRNA Expression Relative to 18S (Determined by RT-qPCR) 
2-Day Stretch in Regular Medium 7-Day Stretch in Osteogenic Medium 
10% (n = 7) 15% (n = 8) 10% (n = 7) 15% (n = 8) 
1.0351 1.6767 0.7260 4.0669 
1.2407 1.7596 1.1605 5.0411 
1.0941 1.5361 1.7357 2.6404 
0.7869 1.0457 1.3927 1.9428 
1.1528 1.0583 0.5576 1.2145 
0.8189 1.4803 0.8129 1.2426 
0.8715 1.7676 0.6147 0.5256 
_ 0.6848 _ 0.4871 
Table A.4 – CHOP mRNA Expression in Stretched Porcine AV Tissues 
CHOP mRNA Expression Relative to 18S (Determined by RT-qPCR) 
2-Day Stretch in Regular Medium 7-Day Stretch in Osteogenic Medium 
10% (n = 8) 15% (n = 8) 10% (n = 7) 15% (n = 8) 
0.9018 1.2171 0.5876 0.5369 
1.2159 1.2843 0.4951 0.7403 
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0.9731 0.8667 0.2311 0.0491 
1.1270 0.8915 0.2941 0.4921 
0.8137 0.6827 2.0633 2.9788 
1.2630 0.9504 1.5007 2.8499 
0.6284 1.2555 1.8282 1.4266 
1.0771 0.8513 _ 1.0928 
Table A.5 – BCL2L1 mRNA Expression in Stretched Porcine AV Tissues 
BCL2L1 mRNA Expression Relative to 18S (Determined by RT-qPCR) 
2-Day Stretch in Regular Medium 7-Day Stretch in Osteogenic Medium 
10% (n = 7) 15% (n = 8) 10% (n = 8) 15% (n = 7) 
0.6282 0.5382 1.8791 1.0314 
1.0388 0.5012 1.2925 0.8472 
0.7282 0.6404 0.9256 0.4764 
1.2812 0.8454 2.2099 0.3040 
1.1111 0.3514 0.5893 0.2968 
0.9466 0.3474 0.3379 0.2108 
1.2658 0.5857 0.3287 0.1172 
_ 0.4095 0.4370 _ 
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A.5.3 Specific Aim 3 
Table A.6 – miR-214 Expression in Transfected Porcine AV Tissues 
miR-214 Expression Relative to U6 (Determined by RT-qPCR) 





Table A.7 – ATF4 and BGLAP mRNA Expression in Transfected Porcine AV Tissues 
ATF4 and BGLAP mRNA Expression Relative to 18S  
(Determined by RT-qPCR) 
ATF4 BGLAP 
Negative Control 
Mimic (n = 8) 
miR-214 Mimic  
(n = 7) 
Negative Control 
Mimic (n = 8) 
miR-214 Mimic  
(n = 7) 
1.5730 0.2230 1.3563 1.1127 
0.6780 0.7801 1.5383 0.9893 
0.9003 0.4315 0.5437 0.8045 
0.3016 1.0301 0.5676 1.0578 
0.4128 0.5919 0.5638 0.9878 
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1.7468 0.4771 1.3187 0.9550 
0.4533 0.7766 0.2621 1.2311 
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